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ABSTRACT 
 
 
 
 Stressful life events, such as receiving a diagnosis of head/neck (HNC) or lung 
cancer, necessarily mobilizes people’s adjustment processes and resources. Creating a causal 
attribution for the event is an important step of this process, and one type of attribution is 
self-blame. Researchers have categorized self-blame based on the tendency to blame one’s 
behaviors (behavioral self-blame; BSB) or dispositional character (characterological self-
blame; CSB). In addition, these subtypes are predicted to differentially impact outcomes, 
with BSB leading to positive outcomes and CSB leading to negative. However, studies 
testing these predictions have found varying effects of BSB and CSB. One anticipated 
explanation for these mixed findings is the measurement tools used for assessing self-blame. 
That is, prior studies have relied almost exclusively on single-items or measures with poor 
psychometric properties to capture this complex construct. In response to this criticism, the 
Self-Blame Attributions for Cancer scale (SBAC) was developed and psychometrically 
analyzed, with results evidencing good internal consistency, convergent validity, and 
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discriminant validity. The purpose of this project was to examine the predictive validity of 
this scale in patients with HNC and lung cancer. An additional goal was to investigate the 
mediating role of control appraisals, or the extent to which patients perceive their cancer 
diagnosis as controllable.   
 Participants (N = 120) were approached who enrolled in radiation and medical 
oncology clinics within six months of receiving a diagnosis of HNC or lung cancer. Self-
report questionnaire packets were administered on the day of enrollment (Time 1) and again 
six weeks later (Time 2). Results showed that BSB was positively and cross-sectionally 
related to tobacco use, and CSB was positively and cross-sectionally related to depressive 
symptoms, avoidant coping strategies, and alcohol use. Longitudinally, neither BSB nor CSB 
was significantly related to Time 2 health outcomes, adjusting for covariates and Time 1 
levels of the outcome variables. In addition, control appraisals did not mediate the 
relationships between either type of self-blame and health outcomes at six-week follow-up. 
The theoretical and clinical implications for providers working in oncology settings are 
discussed.  
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CHAPTER 1 
INTRODUCTION 
Unexpected and negative events, such as cancer, trigger the need for people to 
identify explanations for their diagnosis, or to create causal attributions, which is a primary 
cognitive task that has consequences for intra- and interpersonal functioning, psychological 
adjustment, and mental and physical health (Bennett, 2018). One frequently cited attribution 
in the literature is self-blame, which has been further classified into behavioral (BSB) and 
characterological self-blame (CSB; Janoff-Bulman, 1979). BSB is defined as the tendency to 
blame one’s behaviors for the development of an illness and is hypothesized to be associated 
with better health outcomes via higher levels of perceived control. That is, individuals 
perceive their medical condition as controllable through the modification of certain 
behaviors. These enhanced control appraisals, in turn, lead to better outcomes. On the other 
hand, CSB is thought to be maladaptive for adjustment because blame for the illness is 
attributed to one’s stable disposition, which cannot be easily modified. Without the ability to 
control the cause or trajectory of the illness, individuals engaging in CSB may feel hopeless 
and experience higher levels of psychological distress and other aversive outcomes.  
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Self-blame is an attributional process that may be especially salient for individuals 
with head/neck (HNC) and lung cancer given that behavioral risk factors (e.g., smoking, 
alcohol use) are closely linked to the development of these conditions. However, research 
exploring the differential effects of CSB and BSB in this population (Lebel, Castonguay, et 
al., 2013; Lebel, Feldstain, et al., 2013; Scharloo et al., 2005), as well as many others (e.g., 
Bennett, et al., 2013; Rabin & Pinto, 2006) have yielded mixed results. A possible 
explanation for the nebulous findings is the lack of a validated measure for assessing self-
blame attributions. Therefore, the Self-Blame Attributions for Cancer scale (SBAC; Eways et 
al., 2020) was adapted from a prior cardiac self-blame measure (Harry et al., 2018) and 
validated as an assessment measure of BSB and CSB in patients with cancer.  
The next empirical step was to determine whether the SBAC effectively predicts 
important outcomes in patients with HNC and lung cancer. Thus, this project examined 
relationships between BSB and CSB—as measured by the SBAC—and mental health 
outcomes (depressive and anxiety symptom), physical health outcomes (physical function, 
alcohol use, tobacco use), social function, and the use of avoidant coping strategies in this 
patient population. It was hypothesized that BSB would be positively associated with good 
outcomes and negatively associated with poor outcomes both cross-sectionally (Hypotheses 
#1) and longitudinally (Hypothesis #2). On the contrary, it was expected that CSB would be 
negatively associated with good outcomes and positively associated with poor outcomes 
cross-sectionally (Hypothesis #3) and longitudinally (Hypothesis #4).  
An additional objective was to explore the role of control appraisals to determine 
whether perceived control is a mechanism through which self-blame attributions 
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differentially impact outcomes. Related to this, it was hypothesized that BSB would be 
positively related to Time 1 control appraisals, which in turn would be positively related to 
good Time 2 health outcomes and negatively related to poor Time 2 outcomes (Hypothesis 
#5). For CSB, it was expected that characterological attributions would be negatively related 
to Time 1 control appraisals, which would in turn be positively related to good outcomes and 
negatively related to poor outcomes (Hypothesis #6).  
Participants with HNC and lung cancer were recruited from medical and radiation 
oncology clinics at the University of Kansas Cancer Center. Self-report measures were 
completed on the day of enrollment (Time 1) by 120 participants, with 85 participants 
completing the Time 2 measures six weeks later. Results of hierarchical linear and logistic 
regression analyses did not provide support for Hypothesis #1 or #2 because Time 1 BSB 
was cross-sectionally and positively associated to tobacco use, which was in the opposite 
direction than was anticipated. In addition, BSB was non-significantly related to any other 
Time 1 or 2 health outcomes. Hypothesis #3 was partially supported in that blaming one’s 
character for a diagnosis of HNC and lung cancer was cross-sectionally and positively related 
to depressive symptoms, avoidant coping strategies, and alcohol use. However, CSB was not 
related to any Time 2 outcomes, which was inconsistent with Hypothesis #4. Finally, results 
did not provide support for Hypotheses #5 or #6 because control appraisals were not shown 
to mediate the relationships between either type of self-blame and Time 2 health outcomes. 
These findings indicate that blaming both one’s behavior and character for a 
diagnosis of HNC and lung cancer are concurrently related to poor health behaviors (tobacco 
and alcohol use, respectively). CSB also appears to be linked to other negative outcomes 
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including depressive symptoms and the use of avoidant coping strategies. Therefore, 
oncology providers should aim to assess self-blame in patients with these diagnoses, 
followed by making appropriate referrals to mental health or other supportive services in 
order to address potentially aversive attributional styles and encourage present- or future-
focused orientations.   
Although baseline levels of self-blame were not significantly related to longitudinal 
outcomes and thus failed to provide support for Janoff-Bulman’s (1979) theory and the 
predictive validity of the SBAC, these results still reveal important theoretical implications. 
First, they suggest that replication studies should be conducted with larger and more diverse 
samples. Such studies should also aim to address the limitations of the current project. If, 
after further exploration, comparable results to these are found, the conclusion that BSB does 
not reliability elicit an effect on outcomes may be warranted. Similarly, the non-significant 
mediating role of control appraisals suggests that BSB and CSB do not elicit their effects 
through levels of perceived control. As such, attempts should be made to replicate these 
results. It is also recommended that future research consider exploring perceived control in 
another form, perhaps examining its role as a moderator.  
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CHAPTER 2 
REVIEW OF THE LITERATURE 
Social Cognition 
The field of social psychology has been cognitive since its inception, but it has not 
always been so explicit in its intent to incorporate cognitive principles and techniques. Over 
time, however, the field began borrowing and adapting approaches from finely-tuned 
cognitive theory and methods and applied them to the study of social thoughts, feelings, and 
behaviors (Fiske & Taylor, 2017). This, in turn, ushered in a related but distinct area of 
research known as social cognition, defined as the study of how people think about and make 
sense of themselves and their social worlds (Fiske & Taylor, 2017). As a field, it uses the 
detailed models and concepts of cognitive psychology to measure people’s thinking and 
perceptions in a social world. This is manifested in a wide array of research topics including 
attitudes and persuasion (e.g. Petty et al., 2008), social thinking (Chaiken & Trope, 1999), 
implicit bias (Greenwald et al., 1998; Nosek et al., 2002; Greenwald & Krieger, 2006), self-
concept (Mendoza-Denton et al., 2001; Vignoles et al., 2006), and decision making (e.g., 
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Schwarz, 2000). Another pivotal research area that continues to receive attention and has 
significant implications for outcomes is causal attributions. 
Causal Attributions 
 As people navigate their worlds, they frequently generate causes, or attributions, for 
their own and others’ behaviors. Causal attributions are defined as the creation of causal 
explanations for what may have generated a certain outcome (Howard, 1995). Attributions 
are created following both positive and negative events, and research has consistently shown 
that the cognitive resources devoted to this process vary by the valence of the event (Wong & 
Weiner, 1981). In the case of unexpected and negative events, we tend to engage in more 
intentional and cognitively-laden searches. For instance, receiving a poor performance 
review at work would appropriately cause us to slow down and deliberately process the 
potential causes of the slip-up. On the other hand, receiving a positive review would 
generally require fewer cognitive resources as we can simply attribute the success to our own 
abilities (e.g., excellent work ethic) and move on to the next cognitively pressing task. It is 
much more cognitively efficient and satisfying to automatically take credit for success when 
we can. Regardless of the type of event, it is clear that attributions allow us to make sense of 
human behavior by identifying the cause of it. They also allow us to better predict future 
behavior. Creating causal attributions is, therefore, a fundamental cognitive task that has 
significant and far-reaching implications for intra- and interpersonal functioning, 
psychological adjustment, and physical health (Bennett, 2018; Taylor, 1983). 
Over the last several decades, a great deal of research has been conducted in the field 
of causal attributions, with multiple theoretical perspectives emerging. Most of the classic 
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theories have focused on how we explain other people’s behavior and the errors associated 
with attribution making (Heider, 1958; Jones & Davis, 1965; Kelley, 1973). For example, the 
father of attributional theory, Heider (1958), posited that people scan their environments and 
decide whether the cause of others’ behaviors is internal (i.e., dispositional) or external (i.e., 
situational). Jones and Davis (1965) then expanded Heider’s theory by adding that people are 
motivated to identify dispositional causes of behavior and are thus biased in their 
attributional search.  
More contemporary theories (Arkin & Maruyama, 1979; Taylor, 1983) focus on the 
attributions people create for their own behaviors and how they impact daily functioning. 
These “actor-focused” attributions have been explored in a variety of real-world domains 
including educational achievement (Weiner, 1985) and helping behaviors (Weiner et al., 
1988). Other theories have emphasized the intrapersonal implications of causal attributions, 
specifically how they relate to the process of psychological adjustment. One such theory is 
Taylor’s (1983) theory of cognitive adaptation.  
Theory of Cognitive Adaptation 
 Taylor’s (1983) theory of cognitive adaptation provides a framework for 
understanding the adjustment process in response to personally threatening events, such as a 
trauma. According to the theory, successful adaptation is achieved through modifying one’s 
cognitions to address the current threat and maintaining these changes to protect against 
future adverse events. The process focuses on three main themes: searching for meaning in 
the experience, attempting to regain mastery, and making efforts to enhance one’s self-
esteem.  
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Generating a meaning for the event reflects efforts directed at understanding the 
event, which involves identifying its significance and cause. As such, this is generally the 
process in which causal attributions are highlighted. Meaning-making also focuses on 
reconceptualizing what one’s life will mean or look like following a threatening event. 
Interestingly, it is often the case that individuals perceive their lives as better following a 
traumatizing event. Next, the theme of regaining mastery generally focuses on increasing 
one’s level of perceived control over the specific event and one’s life in general. This 
includes attempts at managing the aftermath of the current event and evaluating the extent to 
which someone feels that they can prevent a similar event from occurring in the future. The 
final cognitive process involves efforts aimed at self-enhancement, which generally occur via 
downward social comparisons. That is, by comparing ourselves to others that are less well-
off, particularly in their coping abilities, we are able to feel more positively about ourselves. 
In Taylor’s (1983) original work, she surveyed 78 women with breast cancer over a 
two-year period to explore the processes that contribute to cognitive adaptation to a serious 
illness. As predicted, Taylor found that meaning-making via the creation of causal 
attributions was a recurring theme endorsed by the vast majority (95%) of patients. These 
attributions included specific or general stress, a specific or environmental carcinogen, 
genetic factors, diet, and some injury to the breast. Importantly, no one causal attribution was 
more strongly related to psychological adjustment than the others suggesting that the overall 
goal of gaining some causal understanding is more significant than the specific type of 
attribution provided. In addition to understanding why the diagnosis occurred, over one-half 
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of the participants also reported that the experience of cancer caused them to reconsider their 
attitudes and priorities and restructure their lives accordingly.  
In addition to causal attributions, Taylor (1983) also explored the theme of regaining 
mastery (i.e., beliefs about personal control) and found that approximately 66% of the 
patients reported some form of control over their cancer. Further, the majority also engaged 
in efforts to heighten their control by using psychological techniques, modifying their health 
behaviors, acquiring additional information about the cancer process, or attempting to control 
the side effects of treatment. Finally, Taylor’s work highlighted the importance of self-
enhancement with the finding that almost all of the participants made downward instead of 
upward social comparisons in an attempt to enhance their self-esteem. In summary, Taylor 
concluded that patients with breast cancer are able to effectively adapt to the health threat by 
producing a causal attribution (meaning-making), enhancing personal control over the threat, 
and increasing their level of self-esteem.  
Although causal attributions are an important component of Taylor’s (1983) theory, 
they do not take center-stage. In fact, very few studies have investigated the role of meaning-
making via causal attributions within her proposed framework. Most research has instead 
prioritized the processes related to regaining mastery and improving self-worth, or the 
benefit-finding that follows meaning-making. There are, however, theorists who have 
developed other frameworks aimed at conceptualizing how attributions affect psychosocial 
health and adjustment.   
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Learned Helplessness Attributions 
Perhaps one of the most influential theories of causal attributions is Abramson, 
Seligman, and Teasdale’s (1978) reformulated learned helplessness model. This theory grew 
out of initial work with animal models (Overmier & Seligman, 1967), which previously 
established a strong link between the experience of uncontrollable events and the engagement 
in subsequent behaviors. For example, when compared to dogs who had previously learned 
to effectively escape a shock in a shuttle box, dogs that had instead received inescapable 
shocks later exhibited few, if any, subsequent efforts to escape the shock even when given 
the opportunity. These responses were also observed in other animal models (e.g., Maier et 
al., 1973) and became known as learned helplessness (Overmier & Seligman, 1967). As 
research in this field gained momentum, investigators began applying the theory to human 
behavior, and they quickly learned that humans’ responses to uncontrollable events were far 
more complex and variable than their nonhuman counterparts. In response, the reformulated 
theory was developed to describe the conditions under which helplessness occurred in people 
and to address the shortcomings of the original model.  
According to the newer theory (Abramson et al., 1978), the attributional process 
begins when an individual first learns that their responses and outcomes are independent of 
one another and seeks to identify a causal explanation for why this has occurred. This 
perceived uncontrollability then leads to deficits in three areas: motivation, cognition, and 
emotion. Motivational deficits are viewed as a reduction in voluntary responses resulting 
from the expectation that consequences are uncontrollable. Next, cognitive deficits refer to 
the idea that exposure to uncontrollable outcomes impedes later learning in that it makes it 
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difficult to recognize that specific responses do in fact produce the respective outcome. 
Likewise, depressed affect or emotion is hypothesized to result from perceptions of low 
perceived control over future outcomes.   
 Whether a person will experience helplessness as a result of these deficits, however, 
depends on a variety of factors. First, compared to the original hypothesis, the reformulated 
model places greater emphasis on cognitive processes, particularly perceptions and 
attributions. In other words, low control over one’s environment itself does not necessarily 
engender feelings of helplessness, but rather individuals’ perceptions of control over their 
environments and the attributions they make for that loss of control aids in defining the 
outcome. Specifically, Abramson et al. (1978) hypothesized that one becomes especially 
susceptible to helplessness when they generate an attribution that is internal, stable, and 
global in nature. Internal reflects an attribution that originates with oneself, as opposed to 
outside or external factors (e.g., other people). Stable is the extent to which the causal factor 
is considered to be long-lasting or recurrent versus short-lived or transient. Finally, global 
represents an attribution that is pervasive and occurs across a wide variety of situations. This 
is contrasted with specific attributions, which refer to those explanations that occur in 
discrete contexts.   
Applying the reformulated learned helplessness model to the etiology of depression, 
Abramson and colleagues (1978) argued that individuals who engage in the pattern of 
making internal, stable, and global attributions for their failures can be described as having a 
pessimistic attributional style, which predisposes them to depression and other adverse 
outcomes. Further, they offered unique consequences that are said to ensue from creating 
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each attribution in response to threatening events: Internal attributions are hypothesized to 
induce low self-esteem; stable attributions are thought to be associated with feelings of 
hopelessness; and global attributions are expected to lead to pervasive helplessness (Bennett, 
2018). Importantly, Abramson et al. (1978) also discussed optimistic attributional styles, but 
the model and subsequent research concentrates much more on the pessimistic type.  
The reformulated learned helplessness model of depression has received much 
empirical support over the last several decades (e.g., Sweeney et al., 1986) and it is now a 
well-validated theory. It has also provided important clinical implications for the prevention 
and treatment of depressive symptoms (Proudfoot et al., 2009). More recently, research has 
begun examining the impact of pessimistic attributional styles in patients with chronic health 
conditions, and there is now evidence that they predict disability in patients with chronic pain 
(Samwel, et al., 2006), poor metabolic control in pediatric patients with diabetes (Kuttner, et 
al., 1990), and higher levels of perceived stress in patients with multiple sclerosis (Vargas & 
Arnett, 2013), to name a few. Connections have also been identified between learned 
helplessness and morbidity (e.g., Levy et al., 2009; Peterson, Seligman, & Vaillant, 1988) 
and mortality (e.g., Peterson, Seligman, Yurko, et al., 1998) rates. Taken together, these 
results suggest that the reformulated learned helplessness model can be applied in both 
medical and mental health settings to better understand attributional processes experienced 
by patients.    
Self-Blame Attributions 
Ronnie Janoff-Bulman (1979) is another researcher who developed a theoretical 
framework to describe the role internal attributions play in psychological processes. Similar 
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to Taylor (1983), she focused on psychosocial adjustment following a threatening life event, 
but she highlighted the cognitive process of self-blame, or the extent to which one attributes 
the occurrence of a stress-inducing event to oneself. Unlike earlier learned helplessness 
theorists (Abramson et al., 1978; Overmier & Seligman, 1967), Janoff-Bulman (1979) 
proposed that the internal attribution of self-blame can, in some cases, be an adaptive 
psychological process. Her theory was informed by an earlier study in which she and 
Wortman (1977) investigated the relationship between self-blame attributions and coping 
patterns in a sample of patients left paralyzed by random accidents. Results revealed that 
self-blame was positively related to adaptive coping strategies. However, the benefits of 
engaging in self-blame were contingent upon one’s perceived control over the accident. 
Specifically, blaming one’s behaviors for the accident was found to be helpful when the 
participants also perceived the accident as unavoidable. In contrast, the combination of low 
self-blame and high perceived avoidance predicted poor post-accident coping. The study’s 
findings eventually led Janoff-Bulman (1979) to deconstruct self-blame into two specific 
categories, behavioral (BSB) and characterological self-blame (CSB), which hinge upon an 
individual’s perceived controllability over the outcome of an aversive event.  
According to Janoff-Bulman (1979), BSB is defined as the tendency to blame one’s 
behaviors for a threatening event and is posited to be associated with better adjustment via 
higher levels of perceived control. On the contrary, CSB is thought to be maladaptive for 
adjustment because blame for the event is attributed to one’s stable disposition, which cannot 
be easily modified. In other words, blaming one’s character is associated with lower levels of 
perceived control, which serves to hinder adjustment. Another distinction involves the 
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temporal orientation of the person engaging in the attribution. Janoff-Bulman (1979) 
proposes that when individuals engage in BSB, they are oriented towards the future in that 
they are concerned with preventing a similar event later on, or avoiding negative outcomes. 
BSB may also involve a more general belief of control over the future and one’s ability to 
generate positive outcomes throughout life. Conversely, individuals engaging is CSB are 
oriented more towards the past, with their focus narrowing on the dispositional factors that 
may be responsible for the event. They may, for example, wonder what it was about them 
that makes them deserving of the unfortunate event.  
In Janoff-Bulman’s (1979) original work, she conducted two studies examining the 
role of self-blame attributions in different contexts. In the first study, she investigated 
whether levels of self-blame differed among female undergraduate students endorsing 
depressive symptoms versus those who did not. She asked the students to imagine that they 
had been faced with a variety of threatening situations (e.g., getting into an automobile 
accident) and then to rate the extent to which they would generally blame themselves at all 
(versus other people, the environment, and chance), blame their behaviors, or blame their 
character. As expected, CSB differed between groups, with higher levels reported by those 
who endorsed more depressive symptoms. Interestingly, the general level of self-blame and 
BSB did not differ between groups. 
In the second study, Janoff-Bulman (1979) surveyed a number of rape crisis centers 
to determine which type of self-blame was most frequently endorsed by victims of rape as 
reported by the counselors of the victims. The counselors reported that the majority of 
victims (74%) blamed themselves at least to some extent for the rape (i.e., general self-
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blame). Of those participants who did blame themselves, approximately 69% were reported 
to endorse BSB, whereas only about 19% were reported to blame their character. Further, the 
centers reported that those engaging in CSB blamed themselves significantly more overall for 
the rape than did behavioral self-blamers. Results of both of the studies led Janoff-Bulman 
(1979) to conclude that self-blame, depending on the type utilized, can be seen as both a 
predictor of good coping (BSB), as well as a correlate of psychological distress (CSB).  
Continuing with Janoff-Bulman’s (1979) initial work, other researchers also 
examined her predictions, with a particular focus on adjustment following recovery from 
sexual assault. Meyer and Taylor (1986) sought to identify victims’ self-blame attributions 
for rape and to clarify relationships between the distinct attributional types (BSB and CSB) 
and psychological adjustment. Importantly, BSB was operationalized as Poor Judgment, 
which consisted of self-report items reflecting the woman’s behaviors, abilities, and attitudes 
towards her rape (e.g., “I should have been more cautious”). CSB was operationalized as 
Victim Type, which was reflected by items related to the victim’s uncontrollable 
characteristics (e.g., “I am a victim type”). Consistent with Janoff-Bulman’s (1979) theory, 
the researchers hypothesized that BSB would be associated with positive outcomes, whereas 
CSB would be associated with more negative outcomes. Contrary to the hypotheses, it was 
found that both Poor Judgment and Victim Type were positively associated with poorer post-
rape adjustment and depressive symptoms.  
Another study conducted by Frazier (1990) also aimed to test Janoff-Bulman's (1979) 
hypothesis in a sample of female participants who were engaging in an ongoing research 
program at a Midwestern medical center. Findings indicated that both BSB and CSB were 
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positively associated with higher levels of post-assault depressive symptoms. Likewise, 
Frazier and Schauben (1994) found that among a sample of survivors of rape, both BSB and 
CSB were associated with poorer recovery. The inconsistent empirical findings from these 
studies have lead researchers (e.g., Ullman, 1996) to conclude that despite Janoff-Bulman’s 
(1979) predictions, both types of self-blame attributions tend to lead to poorer psychological 
adjustment for victims of rape in particular and should be discouraged if possible.   
Self-Blame Attributions and Medical Illnesses 
In addition to examining the role of self-blame on sexual trauma recovery, 
researchers have also investigated the effects of these attributions on outcomes following the 
diagnosis of serious medical conditions. For example, studies including patients with 
sexually transmitted infections (e.g., Manne & Sandler, 1984) have found that CSB is 
associated with worse psychological adjustment following diagnosis. Plaufcan et al. (2012) 
also documented the adverse effects of CSB on concurrent symptoms of depression in a large 
sample (N = 398) of patients with chronic obstructive pulmonary disease (COPD) and 
significant smoking histories. That is, CSB was positively related to symptoms of depression 
while BSB was negatively related to symptoms. Thus, the authors argued that given the 
largely behavioral etiology of COPD, blaming one’s own smoking behaviors allowed the 
participants to experience a sense of controllability over future negative pulmonary events, 
thereby lessening current depressive symptoms.  
Similar findings have been observed in patients with inflammatory bowel disease 
(IBD), a condition for which there is no known cause. In one study (Voth & Sirois 2009), it 
was found that patients with IBD who engaged in CSB used more avoidant coping strategies 
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(defined as the combination of denial and behavioral disengagement), were less likely to 
accept the limitations and difficulties associated with their illness, and were less effective at 
coping with illness-related stress than their counterparts who did not engage in CSB. This 
was contrasted with participants who engaged in BSB who were found to use few avoidant 
coping strategies, endorse greater acceptance of the limitations and difficulties, and 
effectively cope with stress. Janoff-Bulman’s (1979) original work focused on coping and 
psychological adjustment as the most important outcomes, so these findings closely mirror 
her contributions.  
More recently, researchers have begun applying Janoff-Bulman’s (1979) model to 
cardiovascular disease (CVD) patient populations. Like COPD, CVD is also linked to 
specific behaviors (e.g., smoking, poor diet, lack of physical activity) which has led 
investigators to question whether these patients engage in more internal attributions that 
would ultimately impact outcomes. Bennett et al. (2013) examined relationships between 
self-blame attributions and psychological distress in patients with CVD participating in a 
cardiac rehabilitation (CR) program. Results showed that while CSB was unrelated to 
distress concurrently or 12-weeks later at the end of CR, BSB was significantly predictive of 
distress. Specifically, blaming one’s own behaviors for a recent cardiac event (e.g., heart 
attack) at the beginning of rehabilitation was positively related to symptoms of anxiety and 
distress concurrently and at 12-week follow-up. Recognizing that these results departed from 
those described by other researchers (e.g., Voth & Sirois, 2009), Bennett and colleagues 
(2013) posited that their findings may have been due to the low levels of CSB reported by 
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participants. In other words, because the behavioral origins of CVD are well-established, 
patients may be less likely to identify their character as an important etiological factor.  
A related study (Harry et al., 2015) investigated the impact of BSB and CSB on both 
psychological and physical health outcomes in patients with CVD. It was found that CSB 
was unrelated to depressive symptoms 3 months post-diagnosis, but it did predict greater 
cardiac symptom experiences (i.e., chest pain, chest pressure or heaviness, shortness of 
breath) 18 months after CR. In contrast, BSB was shown to have the opposite effect in that it 
positively predicted depressive symptoms at 3-month follow-up but was unrelated to cardiac 
symptom experiences 18 months post-CR.  
Another study (Harry, 2018) examining the effects of BSB and CSB in a sample of 
underserved patients with CVD found that both behavioral and characterological attributions 
were positively related to depressive symptoms and negatively related to mental health 
related quality of life at the beginning of CR (i.e., cross-sectionally), after controlling for 
covariates. While BSB was not related to any of the health outcomes longitudinally (at the 
end of rehabilitation, or approximately 12 weeks later), CSB was negatively related to 
physical health related quality of life, after controlling for covariates and baseline levels of 
the outcome. Taken together, results from both Harry et al. (2015) and Harry (2018) were 
consistent with Bennett and colleagues’ (2013) study in that they failed to provide evidence 
for the beneficial effects of either type of self-blame. 
Self-Blame Attributions and Cancer 
 Attributions of self-blame have been investigated within a variety of medical 
populations as described above. The vast majority of research, however, has focused on 
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assessing for the presence and effects of these attributions in patients diagnosed with cancer 
(e.g., Malcarne et al., 1995), with a particular focus on breast cancer (Bennett et al., 2005; 
Glinder & Compas, 1999; Timko & Janoff-Bulman, 1985). As is the case with other 
illnesses, patients with cancer frequently engage in causal searches aimed at understanding 
why the illness has occurred. This process may be especially salient in oncology populations 
due to the ambiguous etiology and unpredictable course of most cancer types. It could also be 
argued that the sweeping impact of cancer provides sufficient justification for its emphasis in 
the self-blame literature. According to the most recent data (Ferlay et al., 2015), there were 
approximately 14.1 million newly detected cancer cases and 8.2 million cancer-related deaths 
worldwide in 2012. By the year 2025, it is estimated that there will be more than 20 million 
new cancer cases reported annually, with the mortality rate continuing to climb as well. 
Moreover, the financial burden of cancer within the United States alone is currently 
estimated at a staggering $1.16 trillion. Of course, for those who have loved ones with cancer 
or who suffer from cancer themselves, the emotional, psychosocial, and physical burdens are 
also crippling. 
Unfortunately, findings from research investigating the effects of self-blame 
attributions on outcomes in patients with cancer have been mixed. One of the initial studies 
(Timko & Janoff-Bulman, 1985) examined cross-sectional relationships between self-blame, 
perceived vulnerability (i.e., perceived avoidability of cancer recurrence), and psychological 
adjustment (i.e., depressive symptoms) in women with breast cancer who had undergone a 
mastectomy within the last two years. Findings showed that BSB was positively related to 
invulnerability, which was negatively related to adjustment. Thus, while BSB was not 
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directly related to improved health outcomes, the results provided support for the adaptive 
nature of BSB as proposed by Janoff-Bulman (1979). Qualitative data from the study also 
revealed that dispositional attributions were associated with poorer psychological adjustment; 
women who attributed their diagnoses to their personality were more likely to describe 
themselves as people who were unable to cope with difficult situations. This finding was 
consistent with Janoff-Bulman’s (1979) conceptualization of the maladaptive nature of CSB.   
Malcarne et al. (1995) also reported a maladaptive effect of CSB, providing 
additional support to this arm of Janoff-Bulman’s (1979) theory. These researchers examined 
the association between self-blame at the time of diagnosis and psychological distress at 
four-month follow-up in a sample of men and women with various forms of cancer. Baseline 
levels of CSB were found to be unrelated to distress immediately following diagnosis but 
were positively related to psychological distress four months later. Conversely, baseline BSB 
was non-significantly related to both immediate and prospective levels of psychological 
distress. While BSB did not exert any adverse effect per se, the authors reported that the 
findings failed to provide support for its hypothesized beneficial effects and highlighted the 
negative effects of CSB.  
Another study (Glinder & Compas, 1999) focusing on newly diagnosed patients with 
breast cancer assessed the relationship between self-blame and affective distress (i.e., anxiety 
and depressive symptoms) concurrently and prospectively at multiple time points following 
diagnosis: three months, six months, and one year. Cross-sectional analyses indicated that 
blaming one’s behaviors for causing the cancer was positively correlated with affective 
distress at the time of diagnosis and at six-month follow-up. CSB, on the other hand, was 
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significantly related to distress at the three-month post-diagnosis time point. In regards to the 
prospective analyses, BSB did not predict symptoms of distress at any time point, whereas 
CSB significantly predicted distress at six months and one year following diagnosis. The 
researchers concluded that CSB must have long-term deleterious effects, while BSB seems to 
be more detrimental in the moment. These findings were partially confirmed by Friedman et 
al. (2007) who also reported concurrent associations between BSB and distress in patients 
diagnosed with various stages of breast cancer; however, their investigation did not assess for 
the unique contributions of CSB.  
Also surveying a sample of patients with breast cancer, Bennett and colleagues 
(2005) aimed to clarify whether the disparate effects of BSB and CSB on outcomes were a 
function of time since diagnosis as suggested by the aforementioned researchers. Guided by 
the work of Malcarne et al. (1995) and Glinder and Compas (1999), these investigators 
hypothesized that both BSB and CSB would predict more symptoms of anxiety and 
depression shortly after diagnosis (four months), whereas only CSB would predict symptoms 
at seven months and one year post-diagnosis. Results partially supported the hypotheses in 
that both types of self-blame were significantly related to psychological distress at four 
months. However, both forms were also predictive of greater levels of distress at the seven-
months and one-year time points, too.  
The aforementioned studies focused on mental health outcomes and coping processes, 
which is what the majority of causal attributions research tends to highlight. However, some 
studies have also explored the relationship between self-blame and physical health outcomes. 
As mentioned previously, these outcomes were explored by Harry et al. (2015) in relation to 
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CVD. They have also been explored to a greater length in patients with cancer. One 
investigation by Rabin and Pinto (2006) examined the impact of cancer-related beliefs on 
health behavior changes in 65 patients with breast cancer. The researchers found that patients 
who reported believing that an unhealthy diet, insufficient exercise, or alcohol consumption 
contributed to their diagnosis were more likely to modify that respective behavior than the 
patients who did not attribute their illness to those factors.  
Another study (Costanzo et al., 2005) investigated the relationship between cancer 
attributions, psychological distress, and health practices in survivors of gynecological cancer. 
Multiple causal attributions were identified, including controllable factors (e.g., diet, stress, 
alcohol use). More notably, however, was the finding that survivors who made positive 
health changes and obtained regular cancer screenings post-diagnosis were more likely to 
attribute cancer to these controllable factors, namely stress and an unhealthy lifestyle. In 
other words, blaming one’s prior behaviors seemed to serve as a motivating factor for 
changing future health-related behaviors. These two studies provide evidence for the 
protective effect of BSB on physical health outcomes in particular and have important 
implications for improving the health of individuals with cancer.    
Head/Neck and Lung Cancers 
While it is true that the vast majority of research targeting attributions of self-blame 
has focused on cancer, it does not represent all cancer types equally. As mentioned 
previously, the majority of investigations have included heterogeneous samples in terms of 
diagnosis or have focused exclusively on patients with breast cancer. This is surprising given 
the wide range of cancer diagnoses. Moreover, there is empirical evidence suggesting that 
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health outcomes vary as a function of cancer type (e.g., Linden et al., 2012). Another 
important consideration when discussing the effect of self-blame attributions is the etiology 
of the cancer type. While the majority of cancers are thought to be caused by a combination 
of genetic, environmental, and behavioral factors, the relative contribution of each of these 
factors differs by disease group (Danaei et al., 2005; Tao et al., 2015). For example, while 
breast cancer has an extremely strong genetic link (Tao et al., 2015), other cancers have more 
behavioral underpinnings. It can, therefore, be reasoned that the extent to which patients 
blame their behaviors versus innate characterological factors for a cancer diagnosis will at 
least partially depend upon the established etiological factors for that specific diagnosis.  
Two groups of cancers with clear behavioral risk factors are head/neck (HNC) and 
lung cancers. In the case of HNC, tobacco and alcohol use are recognized as two primary risk 
factors (Maasland et al., 2014). More recently, there has also been a significant increase in 
the incidence of the human papillomavirus (HPV)-related HNC, with some estimates 
pointing to extremely high rates (70-90%) of HPV in newly diagnosed oropharyngeal cancers 
(Young et al., 2015). Likewise, the majority of lung cancer cases can be attributed to 
cigarette smoking (e.g., Islami et al., 2015) Given that these factors are largely avoidable, 
patients with HNC and lung cancer may be especially susceptible to blaming their behaviors 
for the onset of cancer. Indeed, it has been found that patients with lung cancer endorse 
higher levels of BSB than patients with other types of cancer including breast and prostate 
(Else-Quest et al., 2009). Greater experiences of self-blame may then, in turn, impact 
outcomes. Thus, HNC and lung cancer patient populations provide a ripe arena for self-
blame research.   
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In addition to the enhanced susceptibility for patients with HNC and lung cancers to 
engage in self-blame processes, these two subtypes of cancer are also widely prevalent and 
combined impact millions of people per year. Lung cancer, for example, is the leading cause 
of cancer-related death for both men and women in the United States (Islami et al., 2015; 
Torre et al., 2016), and the most recent prevalence data indicate that more than 500,000 
people are currently living with the disease (Howlader et al., 2016). When considering 
incidence, it is estimated that there were approximately 222,500 new cases of lung and 
bronchus cancer diagnosed in the United States in 2017, representing 13.2% of all new 
cancer cases. Of these cases, about 155,000 individuals will eventually die of the disease and 
only about 18% will survive beyond five years (Howlader et al.). One explanation for the 
poor prognosis and mortality rates is due to the fact the majority of patients (approximately 
70%) present with locally advanced or metastatic disease at the time of diagnosis (Molina et 
al., 2008). Of note, rates tend to vary by gender and race, with a higher occurrence in men, 
specifically Black/African American men. In addition, individuals are generally diagnosed 
between the ages of 65 and 74 (M age = 70).  
Cancer of the head/neck is comprised of a large group of tumors at various 
anatomical sites including the oral cavity, oropharynx, larynx, tonsils, paranasal sinuses, 
nasal cavity, and salivary glands (Simard et al., 2014). According to the most recent 
epidemiological research (Howlader et al., 2016; Pfster et al., 2015), more than 600,000 
cases occur worldwide, with about half of that number dying of the disease each year. In the 
United States, prevalence rates are lower, with HNC ranked as the 8th most common cancer 
diagnosis; it is estimated that there were between 45,000 and 50,000 new cases in 2017, or 3-
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4% of all new cancer diagnoses. Compared to lung cancer, the average mortality rate is far 
better, with fewer than 12,000 patients dying annually (Vigneswaran & Williams, 2014). In 
addition, the five-year relative survival rate exceeds 64%. Regarding the demographic 
presentation of patients, individuals typically have a mean age of 63 years at the time of 
diagnosis, although rates in younger people are on the rise. Men are far more likely than 
women to receive a HNC diagnosis, with a relatively equal spread among racial/ethnic 
groups.  
Treatments for both HNC and lung cancer have made remarkable advances over the 
last several years, and there are now a myriad of options available to patients. In general, 
modalities tend to consist of surgery, radiation, chemotherapy, or some combination of the 
three (Adelstein et al., 2017; Miller et al., 2016; Molina et al., 2008). Within the oncology 
literature, treatments are often described as single-modality or combined modality (Adelstein 
et al., 2017). Single-modality treatments consist of surgery or radiation therapy alone and are 
frequently recommended for patients with early-stage disease. Surgical resection is generally 
utilized with a curative intent, with the aim of removing the totality of the disease (i.e., tumor 
and surrounding lymph nodes). Radiation therapy utilizes high-energy radiation to target a 
localized tumor site. Put simply, radiation is designed to destroy the cancerous cells and 
effectively shrink the size of the tumor. Radiation is generally administered on a daily basis 
for a total of six weeks for HNC and seven weeks for lung cancer. However, dose and 
number of treatments is contingent on a variety of factors such as tumor site and the patient’s 
tolerance of the treatment and its side effects.  
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Combined modality therapy generally includes some form of systemic therapy and is 
common for those with locally advanced or metastatic disease (Adelstein et al., 2017; Pfster 
et al., 2015). Chemotherapy is the most common form of systemic therapy and is 
administered intravenously or orally. With advances in science, there are now dozens of 
chemotherapy medications available with a variety of mechanisms of action. In addition to 
the more traditional therapies documented here, other novel approaches, such as 
immunotherapies, have recently been approved for the treatment of some cancer types and 
are showing promise in terms of prognosis and quality of life (Miller et al., 2016). Tables 1 
and 2 summarize the common treatment options for HNC and lung cancer by stage, 
respectively (Miller at al.). However, it is important to note that multiple factors including 
primary tumor site, pathology and histology, tumor biomarkers, patient preferences, and 
patient characteristics (e.g., age, medical comorbidities, functional status, previous cancer 
diagnosis, treatment side effects, smoking status) guide treatment recommendations and 
guidelines. 
 
Table 1 
Common Treatment Recommendations for HNC by Stage 
Stage Common Treatment Recommendations Other Treatment Options 
I Surgical resection or radiation  Immunotherapy for recurrent or 
metastatic disease   
II Surgical resection or radiation 
  
III Surgical resection, radiation, and/or 
chemotherapy; clinical trials 
  
IV Surgical resection, radiation, and/or 
chemotherapy; clinical trials 
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Table 2 
 
Common Treatment Recommendations for Lung Cancer by Stage 
 
Stage Common Treatment Recommendations Other Treatment Options 
I Surgical resection + chemotherapy and/or 
radiation 
Angiogenesis inhibitors, 
epidermal growth factor receptor 
inhibitors, anaplastic lymphoma 
kinase inhibitors 
  
II Surgical resection + chemotherapy and/or 
radiation 
  
III Chemotherapy with radiation; clinical trial; 
immunotherapy 
  
IV Chemotherapy with or without radiation; 
clinical trial; immunotherapy 
 
 
 
Self-Blame Attributions and Head/Neck and Lung Cancers 
Given the behavioral risk factors for HNC and lung cancers, the prevalence and 
incidence of these conditions, and the harrowing treatments patients are exposed to, one 
would expect that the predictors of outcomes within this population would be explored in 
full. Unfortunately, research is relatively limited overall, and the same is true for research on 
attributions. Although there have been some investigations looking at self-blame attributions 
in particular, the research examining differential effects of BSB and CSB on outcomes is 
surprisingly sparse. And, the research with HNC and lung cancer samples has focused almost 
exclusively on BSB, and results have been inconsistent overall. On one hand, there are data 
pointing to the deleterious influence of BSB on health outcomes: an inquiry by Lebel, 
Castonguay, et al. (2013) investigated the determinants of perceived stigma in a sample of 
patients diagnosed with primary or recurrent lung (n = 107) or HNC (n = 99). Guided by  
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past work (Else-Quest et al., 2009) citing a positive correlation between general self-blame 
(i.e., the combination of self-blame, shame, and guilt) and self-stigma in people with lung 
cancer, the researchers hypothesized that BSB—defined as the extent to which patients 
believed their cancer was caused by tobacco or alcohol use—would be positively associated 
with stigma perceptions. Results failed to support the hypothesis: BSB was not a significant 
predictor of stigma. However, it was positively related to psychological distress, suggesting 
that blaming one’s own behaviors for these types of cancer does not provide many 
psychologically-protective effects. 
Another study (Scharloo et al., 2005) focusing exclusively on patients with recently 
diagnosed HNC examined the effect of illness perceptions (e.g., self-blame attributions) on 
quality of life. The authors found that low levels of endorsement of the belief that one’s own 
behavior (alcohol and tobacco use) caused the disease and a less strong emotional response to 
the diagnosis were both associated with better social functioning. This finding was later 
confirmed with a follow-up study (Scharloo et al., 2010) that aimed to extend the work of 
Scharloo et al. (2005) by analyzing the effect of baseline illness perceptions on quality of life 
longitudinally, or two years after diagnosis. In the more recent investigation, the researchers 
(2010) found that lower levels of cancer-related BSB at the time of diagnosis were 
prospectively predictive of better physical, social, and role functioning, as well as better 
global health. In other words, the less patients focused on their behaviors as a source of 
blame for the development of their disease, the better off they were. These results effectively 
confirmed the cross-sectional findings of the original study (Scharloo et al., 2005). 
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On the other hand, researchers have also documented the advantages of engaging in 
behavioral-based attributions. One example is a study conducted by Lebel, Feldstain, et al. 
(2013), which assessed the role of BSB and stigma in predicting the adoption of positive 
health changes in survivors of HNC and lung cancer. Of note, these analyses were conducted 
with the same patient sample as Lebel, Castonguay, and colleagues (2013), and BSB was 
again defined as attributing one’s cancer diagnosis to prior alcohol or tobacco use. Findings 
indicated that while stigma was unrelated to positive health changes following diagnosis, 
participants who generated behavioral attributions for their diagnoses made significantly 
more changes than those who made no such attributions. Further, the combination of BSB 
and stigma was associated with a reduction in tobacco use. These data suggest that when the 
diagnosis of cancer is deemed controllable via the modification of risky health behaviors, 
patients are motivated to change those behaviors, which ultimately enhances positive 
outcomes. Thus, this work largely mirrored the findings reported Costanzo et al. (2005) and 
Rabin and Pinto (2006) who documented evidence for the protective effects of BSB on 
physical health outcomes.   
 Christensen et al. (1999) were also interested in determining the effect of BSB on the 
probability of continued tobacco and alcohol use following the specific diagnosis of HNC. 
Furthermore, they explored the effect of perceived control over cancer recurrence as a 
moderator of this relationship. Consistent with their hypotheses, the researchers reported that 
participants who engaged in BSB had a high probability of continuing to smoke, but only if 
their perceived levels of control were low. This was contrasted with patients who reported 
high levels of both behavioral attributions and perceived control, as they were found to have 
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a far lower probability of smoking post-diagnosis. Interestingly, analyses testing the 
combined effect of BSB and perceived control on drinking behaviors revealed no significant 
main or interactive effects. Taken together, these results indicate that BSB can be a beneficial 
cognitive process in patients with HNC but only if they also believe that their future recovery 
and health is dependent upon their own health behaviors. 
The Role of Control Appraisals 
 While Janoff-Bulman (1979) offered perceived control as a mechanism by which 
self-blame elicits its effects on outcomes, and some studies have attempted to assess the 
moderating effects of control on outcomes (e.g., Christensen et al., 1999), very few inquiries 
have examined its role as a mediator. And, similar to the other work with self-blame 
attributions, findings have varied. Guided by Janoff-Bulman’s (1979) framework, Malcarne 
et al. (1995) proposed a mediation model whereby it was hypothesized that initial BSB 
would be positively related to perceived control, which would in turn be negatively related to 
psychological distress. They also predicted that CSB would be negatively related to control, 
which would be related to greater psychological distress. In contrast to their hypotheses, 
perceived control was not a significant mediator of the relationship between either type of 
self-blame and distress. Further, BSB was unrelated to control beliefs or psychological 
distress 4 months later.  
 Bennett et al. (2005) also sought to determine whether perceived control mediated 
relationships between CSB, BSB, and distress in a sample of patients with breast cancer. The 
researchers examined two different types of control: Control over cancer recovery and 
control over recurrence. Similar to Malcarne et al.’s (1995) work, results failed to support a 
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mediating role of control. Another study (Bennett et al., 2013) analyzed both concurrent and 
prospective relationships between self-blame and perceived control in a sample of patients 
with CVD participating in a CR program. Results indicated that CSB was cross-sectionally 
and negatively related to control over general cardiac health, control over cardiac event 
recovery, and overall control. In addition, blaming one’s specific behaviors—diet and 
exercise—was positively correlated with control over preventing cardiac event recurrence. 
These results were consistent with Janoff-Bulman’s (1979) predictions, but it is important to 
note that few associations were found between self-blame attributions and control 
prospectively.  
 One additional investigation (Harry, 2018) attempted to characterize the role of 
control appraisals as a mediating variable in underserved patients with CVD. For this study, 
BSB, CSB, and control appraisals were assessed at the beginning of CR (Time 1), and a 
number of health outcomes were assessed 12-weeks later at the end of CR (Time 2), 
including depressive symptoms, mental and physical health related quality of life, adherence 
to a heart healthy diet, and functional capacity. Analyses showed that control appraisals did 
not significantly mediate the relationships between BSB, CSB, and any of the outcome 
measures after controlling for covariates and baseline levels of the outcome variables. 
However, Time 1 BSB was unexpectedly found to be negatively related to Time 1 control 
appraisals in the mediation models that controlled for number of CR sessions. Furthermore, 
Time 1 control appraisals were shown to be longitudinally and positively related to mental 
health related quality of life with both BSB and CSB as the predictors.  
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Development of the Self-Blame Attributions for Cancer Scale 
In summary, the numerous empirical contributions exploring the differential effects 
of CSB and BSB on outcomes have yielded some support for Janoff-Bulman’s (1979) model, 
but results have in many cases been inconclusive. Further, the mechanism by which self-
blame attributions are hypothesized to shape outcomes—via perceived control—has not been 
corroborated in the literature. One possible explanation for these nebulous findings is the 
absence of a valid and reliable tool for the measurement of self-blame attributions. For 
example, many prior researchers have relied upon one-item measures. In one study, Glinder 
and Compas (1999) used the following questions to assess BSB and CSB, respectively, in a 
sample of patients with breast cancer: “How much do you blame yourself for the kinds of 
things you did, that is, for any behaviors that led to your cancer?”, and 2) “How much do you 
blame yourself for the kind of person you are, that is, for being the kind of person who has 
things like cancer happen to them?" (p. 47). Other researchers have generally followed suit; 
in fact, the vast majority of the studies reviewed here (N = 11) assessed self-blame 
attributions using the same or very similar single-item measures as Glinder and Compas 
(Bennett et al., 2005; Bennett et al., 2013; Lebel, Castonguay, et al., 2013; Lebel, Feldstain, 
et al., 2013; Malcarne et al. 1995).   
Even when multi-item self-report scales are employed, researchers tend to develop 
items solely for one individual study (Christensen et al., 1999; Manne & Sandler, 1984) or to 
adapt items from other scales to formulate composite measures of self-blame attributions 
(Plaufcan et al., 2012; Scharloo et al., 2005; Scharloo et al., 2010). In both cases, the 
resulting measurement tools are rarely subjected to rigorous statistical analyses. For instance, 
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in two similar studies assessing the relationship between BSB and cross-sectional (Scharloo 
et al., 2005) and longitudinal outcomes (Scharloot et al., 2010) in patients with HNC, 
researchers operationalized BSB as the combination of three items from the Illness 
Perception Questionnaire-Revised (Moss-Morris et al., 2002) that assessed the extent to 
which participants attributed their diagnosis to their own behavior, alcohol, or smoking. Of 
note, the decision to combine these three items was not grounded in prior empirical evidence; 
rather, it was dictated by the frequency of endorsement of those respective attributions, 
thereby potentially inflating estimates. In addition, while the authors were able to 
demonstrate that the composite measures had good internal consistency in the initial (α = .88) 
and follow-up study (α = .80), they did not provide any additional information about other 
important psychometric properties, such as convergent and discriminant validity. 
These above-mentioned approaches to measurement introduce a variety of crucial 
methodological and statistical issues that have been frequently criticized in the literature. For 
example, reliability coefficients cannot be calculated for single-item measures (Clark & 
Watson, 1995), and a one-item measure is unlikely to effectively capture the full complexity 
of the construct of self-blame (Hoeppner et al., 2011). In regards to the individually-
developed and adapted items and measures, these processes introduce the potential for 
measurement error as each researcher is free to develop the items in a different way. As 
previously mentioned, researchers also infrequently analyze the psychometric properties of 
the adapted items or scales to ensure that they exhibit adequate reliability and validity. 
Therefore, it can be argued that the current self-report measurement tools used for assessing 
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self-blame attributions are inadequate and need to be improved in order to effectively and 
accurately capture this construct. 
In response to these salient limitations, Harry et al. (2018) recently developed and 
validated the Cardiac Self-Blame Attributions Scale (CSBA) for measuring self-blame 
attributions in patients with CVD. The CSBA was administered to 121 participants who were 
recovering from a cardiac event in an inpatient cardiology unit of a Midwestern hospital. The 
final exploratory factor analysis using principal axis factoring with oblimin rotation yielded 
an 11-item scale with two distinct factors representing BSB (six items) and CSB (five items). 
The internal consistency for each factor (α = .93 and α = .87, respectively) and the entire 
scale was excellent (α = .93). In addition, the total CSBA scale, and the BSB and CSB 
subscales were non-significantly related to exercise self-efficacy (r = -.13, r = -.10, r = -.14, 
ps > .05, respectively), providing evidence for discriminant validity. Overall, the results 
confirmed that the CSBA is a valid and reliable tool for assessing self-blame attributions in 
patients with CVD.  
A follow-up study conducted by Harry (2018) aimed to further validate the CSBA 
scale and examine its predictive validity in patients completing a CR program. Results 
confirmed the two-factor structure of the CSBA scale and provided evidence for good 
internal validity and test-retest reliability. It was also found that both BSB and CSB at the 
beginning of CR (Time 1) were positively related to depressive symptoms and negatively 
related to mental health related quality of life cross-sectionally. In addition, CSB at Time 1 
was significantly and negatively related to physical health related quality of life at the end of 
CR (Time 2). Neither behavioral nor characterological attributions elicited a longitudinal 
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effect on health outcomes at Time 2. Thus, these results provided support for the use of the 
CSBA scale for assessing the relationships between self-blame and cross-sectional but not 
long-term outcomes in patients with CVD.  
Unfortunately, no measure akin to the CSBA existed to measure self-blame 
attributions in patients with cancer, thus necessitating the development of a scale to be used 
with this population. Given the strong psychometric properties of the CSBA, Eways et al. 
(2020) sought to adapt and validate it for use with patients diagnosed with cancer. First, the 
scale was adapted by simply replacing the word “cardiovascular disease” with the word 
“cancer” for each individual item (see Appendix A-2). Second, the adapted scale, referred to 
as the Self-Blame Attributions for Cancer Scale (SBAC), along with multiple other self-
report measures, was administered to patients with various forms of cancer who were 
currently receiving radiation treatment at a Midwestern university medical center. A total of 
113 participants completed the study. The mean age of participants was 50.97 years (SD = 
13.33), and the majority of participants was female (52.2%) and European American 
(79.6%). The most common diagnoses were HNC (33.6%), breast (21.2%), and 
gynecological (18.6%) cancers. Other diagnoses included lung (1.8%), prostate (3.5%), brain 
(5.3%), melanoma (1.8%), hematological (2.7%) colon (5.3%) pancreatic, (0.9%), and non-
melanoma skin (1.8%).  
An exploratory factor analysis with principal axis factoring using an oblimin rotation 
was conducted to determine the factor structure of the SBAC. Parallel analysis indicated that 
two factors should be extracted. The two factors explained 75.7% of the variance and, as 
expected, represented BSB (six items) and CSB (five items). Primary pattern matrix 
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coefficients ranged from .59 to .99, with no cross-loadings greater than .35. The BSB and 
CSB subscales exhibited excellent internal consistency (α = .95 and α = .93).  
Significant associations were found between the internal subscale of Form C of the 
Multidimensional Health Locus of Control scale and the BSB (r = .33, p < .001), and CSB 
subscales (r = .29, p < .01), providing evidence for convergent validity. Additionally, the 
BSB and CSB subscales demonstrated good discriminant validity with the sleep subscale of 
the Patient-Reported Outcomes Measurement Information System-43 version 2.0 (PROMIS-
43), as evidenced by weak and non-significant correlations between these measures (r = .11 
and r = .09, ps > .05, respectively). Taken together, these preliminary results indicate that the 
SBAC is a valid and reliable scale for measuring self-blame attributions in patients with 
various forms of cancer.  
Importance of the Proposed Outcomes 
The number of specific self-blame outcomes explored by Janoff-Bulman (1979) and 
other attribution researchers are plentiful. However, when reviewing the literature, four main 
themes quickly emerge: psychological adjustment (Bennett et al., 2005; Janoff-Bulman, 
1979; Malcarne et al., 1995; Plaufcan, et al., 2012), which is generally conceptualized as 
symptoms of distress; physical health outcomes (Costanzo et al., 2005; Janoff-Bulman, 1979; 
Harry et al., 2015; Harry, 2018; Rabin & Pinto, 2006); social functioning (Scharloo et al., 
2005, Scharloo et al., 2010), and coping processes (Janoff-Bulman, 1979; Janoff-Bulman & 
Worman, 1977; Voth & Sirois, 2009). These themes are also extremely pertinent concepts 
when considering the experiences of patients with HNC and lung cancer and thereby offer 
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themselves as suitable outcomes for assessing the impact of self-blame on the lives of these 
patients.   
First, consider the case of psychological distress or mental health. Receiving a 
diagnosis of HNC or lung cancer can have far-reaching and often times devastating 
psychosocial impacts for patients and their families. At the outset, patients are faced with a 
life-threatening disease process, which can lead to an onslaught of psychological distress. 
Next, they are instructed to undergo invasive medical treatments with an endless list of 
unpleasant side effects. Not surprisingly, individuals diagnosed with these types of cancer 
often endorse symptoms of anxiety and depression that far exceed those of the general 
population (Howren et al., 2013; Moubayed et al., 2015). While rates of psychological 
distress tend to vary as a function of the measurement method used, one study found that 
depression rates reached 43% before treatment and 44% after treatment in patients with HNC 
(Moubayed et al.). Other estimates range between 15% and 50% (Howren et al., 2013). 
When compared to depression, symptoms of anxiety have been studied to a lesser extent, but 
estimates do suggest that many patients struggle with these symptoms (7 to 30%), and they 
frequently commence well before the initiation of treatment (Chen et al., 2009; Neilson et al., 
2010; Pandey et al., 2007).  
Psychological distress is also highly prevalent in patients diagnosed with lung cancer. 
For example, it has been reported (Zabora et al., 2001) that approximately 40% of patients 
with lung cancer endorse symptoms of significant psychological distress, representing one of 
the highest prevalence rates of all cancers. This finding was later confirmed by a longitudinal 
study (Linden et al., 2012) documenting subclinical and clinical levels of anxiety at 48.3% 
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and 25.7%, respectively, and depression rates higher than 35% (subclinical) and 17% 
(clinical). One likely explanation for these rates of distress is the poor prognosis that 
typically accompanies lung cancer at the time of diagnosis, particularly in late-stage disease. 
Given the prevalence of anxiety and depressive symptoms in both HNC and lung cancer, 
psychological distress is a valuable outcome to study in these patient populations.  
In addition to mental health outcomes, cancer also elicits aversive effects on physical 
outcomes (e.g., physical functioning and substance use), and the extent to which patients are 
able to engage in social activities and roles (i.e., social functioning). In the case of HNC, both 
the tumor and treatment modalities (e.g., extensive surgery, radiation therapy) often lead to 
significant and visible disfigurement, as well as a host of unpleasant side effects including 
difficulties breathing, swallowing, and speaking; severe pain; and impairments in sense of 
smell and taste (Dunne et al., 2017). Understandably, patients are often hesitant to spend time 
in public and are frequently limited in their abilities to engage in daily pleasurable social 
activities such as eating and conversing with others (Dunne et al.). Similarly, patients with 
lung cancer have been found to exhibit a significant decline in physical activity, functional 
capacity, and strength following the diagnosis, with their engagement in social roles closely 
mirroring this decline (Granger et al., 2014; Murray et al., 2007). Furthermore, patients tend 
to have significantly worse physical status compared to their “healthy” counterparts both 
during and after treatment. Across a wide variety of cancers, another surprising yet 
frequently identified physical health outcome is continued substance use, namely alcohol and 
tobacco use. For example, it has been shown that over 50% of cancer survivors who smoked 
pre-diagnosis continue to smoke afterwards (Blanchard et al., 2003). Unfortunately, the 
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continued engagement in these poor health behaviors puts patients at risk for recurrence, the 
development of additional primary cancers, and late-onset treatment side effects (Rabin & 
Pinto, 2006; Zablotska & Negut, 2003). Thus, physical health outcomes—including 
substance use—and social functioning are important proxies for patients’ quality of life and 
are closely linked to important distal outcomes, such as morbidity and mortality (Granger et 
al., 2014).  
Another process that a cancer diagnosis naturally elicits is coping. Lazarus (1993) 
defined coping as cognitive and behavioral efforts aimed at managing external or internal 
demands that are appraised as threatening. A cancer diagnosis would undeniably qualify as 
such a demand, thereby necessitating the mobilization of cognitive and behavioral resources 
in order to effectively manage the diagnosis itself, subsequent treatments, and other various 
sequelae. It is important to note, however, that coping strategies vary widely and have 
differential impacts on outcomes (Lazarus). One coping strategy frequently reported by 
patients with HNC and lung cancer is avoidant coping, defined as thinking or behaving as if 
the threatening event (i.e., cancer diagnosis) has not occurred (Aarstad et al., 2008; Lazarus, 
1993). Examples of avoidant coping strategies cited in the literature include behavioral 
disengagement, mental disengagement, self-distraction, and denial (Aarstad, et al., 2011; 
Aarstad et al., 2008; Voth & Sirois, 2009). For instance, Sherman et al. (2000) reported that 
patients relied heavily on denial (e.g., “refusing to believe that this has happened”) and 
behavioral disengagement (e.g., “just giving up trying to deal with it”) when actively 
receiving or recently completing treatment for advanced stage HNC. In a study involving 
patients with lung cancer, Oancea et al. (2018) also found that over 27% of the patients 
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endorsed avoidant coping strategies (denial, mental and behavioral deactivation) at the time 
their diagnosis was confirmed, and the majority maintained this strategy at three-month 
follow-up. Another qualitative-based study (Liao et al., 2018) specifically examined female 
patients with incurable lung cancer and identified avoidant coping as one of the top four most 
frequently used coping resources.  
Beyond being a commonly used coping strategy in patients with HNC and lung 
cancer, there is also substantial evidence that avoidant coping is related to adverse outcomes 
and is thus worth examining in this population (Aarstad et al., 2008; Aarstad et al., 2011 
Eadie & Bowker, 2012; List et al., 2002). In one study, Aarstad and colleagues (2008) 
examined the impact of avoidant coping on long-term outcomes in patients who were 
successfully treated for HNC. Results indicated that a high level of avoidant coping (denial, 
behavioral and mental disengagement) and drinking to cope approximately four years post-
diagnosis predicted poorer quality of life three to four years later. A later study (Aarstad et 
al., 2011) using the same sample of patients investigated the relationship between avoidant 
coping and outcomes approximately one-year post-diagnosis. Again, findings indicated that a 
high level of behavioral disengagement was associated with worse quality of life. In the case 
of lung cancer, a recent study (Oancea et al., 2018) examined changes in depression and 
anxiety over a one-month period and whether these changes varied by the coping 
mechanisms used. Not surprisingly, it was found that those patients who reported avoidant 
coping strategies at baseline had the most prominent increase in depressive and anxiety 
symptom scores between baseline and one-month follow-up. These outcomes were 
corroborated by Walker et al., (2006) who also showed that coping characterized by 
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disengagement and denial was associated with more severe depressive symptoms in a sample 
of lung cancer patients who had recently undergone surgical resection.  
Gaps in the Literature and Hypotheses 
As detailed above, it has long been established that cancer processes elicit deleterious 
effects on psychological distress and physical health (physical functioning and substance use) 
outcomes in patients. There is also evidence that these processes impact one’s ability to 
function in social roles and engender avoidant coping strategies that, in turn, exacerbate the 
already negative effects of the illness. It is now imperative that front-end predictors to 
psychological distress, physical health outcomes, social functioning, and avoidant coping are 
better understood in the context of HNC and lung cancer. Self-blame attributions is one such 
predictor in that it has been repeatedly linked to outcomes in populations adjusting to 
stressful life events, such as the diagnosis of cancer. This construct is also likely to be 
especially pertinent to patients with HNC and lung cancer due to the behavioral 
underpinnings (e.g., alcohol and tobacco use) of these conditions. What is less clear in the 
literature, however, is the unique contributions of BSB and CSB and whether they 
differentially influence outcomes. While CSB generally predicts poorer outcomes, the effects 
of BSB vary from study to study.  
One possible explanation for these inconsistent findings is the lack of a well-validated 
measurement tool developed specifically for the assessment of self-blame attributions. Prior 
attempts at measurement have included single-items (Glinder & Compas, 1990) and freely 
developed or adapted measures for the use in one specific study (Manne & Sandler, 1984; 
Scharloo et al., 2005). Recognizing the host of statistical and methodological errors 
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introduced by these approaches to measurement, the SBAC was developed and validated to 
more effectively capture self-blame attributions in patients with cancer; however, its 
predictive validity remains unknown. Thus, the current project aimed to fill these gaps in the 
literature by establishing the predictive validity of the SBAC. Specifically, this study 
examined whether the SBAC would predict psychological distress (i.e., symptoms of anxiety 
and depression), physical health outcomes (i.e., physical functioning and substance use), 
social functioning, and the use of avoidant coping strategies in patients with HNC and lung 
cancer. In addition, the current study further explored the role of control appraisals in order 
to determine whether perceived control over one’s cancer diagnosis mediates the effect of 
self-blame on outcomes.  
It is important to note that findings regarding the unique effects of BSB and CSB on 
outcomes have varied throughout the literature, and BSB has in many cases been negatively 
associated with outcomes despite Janoff-Bulman’s (1979) hypotheses. Nonetheless, the 
present hypotheses were consistent with Janoff-Bulman’s (1979) original self-blame 
attributions model because this is the first study that has utilized a well-validated measure to 
assess her proposed theory in patients with HNC and lung cancer. Thus, guided by Janoff-
Bulman’s (1979) original work, the following hypotheses were tested:  
Hypotheses for Behavioral Self-Blame 
Hypothesis #1 
BSB at the time of enrollment (Time 1) would be positively related to good outcomes 
(i.e., physical functioning and social functioning) and negatively related to poor outcomes 
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(i.e., anxiety symptoms, depressive symptoms, avoidant coping, substance use) cross-
sectionally.  
Hypothesis #2 
BSB at Time 1 would be positively related to good outcomes (i.e., physical 
functioning and social functioning) and negatively related to poor outcomes (i.e., anxiety 
symptoms, depressive symptoms, avoidant coping, substance use) at six-week follow-up 
(Time 2), controlling for Time 1 levels of the dependent variables.  
Hypotheses for Characterological Self-Blame 
Hypothesis #3 
CSB at Time 1 would be negatively related to good outcomes (i.e., physical 
functioning and social functioning) and positively related to poor outcomes (i.e., anxiety 
symptoms, depressive symptoms, avoidant coping, substance use) cross-sectionally.  
Hypothesis #4 
CSB at Time 1 would be negatively related to good outcomes (i.e., physical 
functioning and social functioning) and positively related to poor outcomes (i.e., anxiety 
symptoms, depressive symptoms, avoidant coping, substance use) at Time 2, controlling for 
Time 1 levels of the dependent variables. 
Hypotheses for Control Appraisals as a Mediator  
Hypothesis #5 
Time 1 control appraisals would mediate the relationship between Time 1 BSB and 
Time 2 outcomes. Specifically, BSB would be positively related to Time 1 control appraisals, 
which would in turn be positively related to good outcomes (i.e., physical functioning and 
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social functioning) and negatively related to poor outcomes (i.e., anxiety symptoms, 
depressive symptoms, avoidant coping, substance use), controlling for Time 1 levels of the 
dependent variables.  
Hypothesis #6 
Time 1 control appraisals would mediate the relationship between Time 1 CSB and 
Time 2 outcomes. Specifically, CSB would be negatively related to Time 1 control 
appraisals, which would in turn be positively related to good outcomes (i.e., physical 
functioning and social functioning) and negatively related to poor outcomes (i.e., anxiety 
symptoms, depressive symptoms, avoidant coping, substance use), controlling for Time 1 
levels of the dependent variables.  
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CHAPTER 3 
METHODOLOGY 
Participants 
 Institutional Review Board approval was obtained from the University of Kansas 
Medical Center prior to the start of participant recruitment. This project recruited participants 
from outpatient medical and radiation oncology clinics at the University of Kansas Cancer 
Center (KUCC). Patients referred to these clinics presented for appointments assessing their 
response to and progress throughout treatment. The radiation oncology clinics include 
patients presenting for radiation treatment. The medical oncology clinics generally see 
patients who are currently undergoing a chemotherapy and/or immunotherapy treatment 
regimen. Many patients receive care from both clinics simultaneously depending on their 
treatment plan. The following inclusion criteria were used for recruitment: 1) At least 18 
years old, 2) English speaking, 3) Diagnosed with primary HNC or lung cancer, 4) Self-
reported diagnosis within the last six months, 5) Absence of a second known primary cancer 
diagnosis, 6) No cognitive or physical impairments that would impede their ability to 
complete the study materials at Times 1 and 2, and 7) Currently receiving care at KUCC and 
anticipation that the participant will continue to receive care there for at least six weeks 
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following the enrollment date. Importantly, while participants may have received their initial 
diagnosis up until six months prior to enrollment, efforts were made to enroll patients as soon 
as possible after their diagnoses in an attempt to ensure their attributional processes were 
salient.  
 Recruitment took place from July 2018 to December 2019. A total of 179 patients 
were approached for participation in this study, with 128 agreeing to participate (71.5%). 
Figure 1 displays the flow of participant recruitment, including the reasons patients declined 
to participate. Of the 128 individuals who were enrolled into the study, seven failed to 
complete the Time 1 survey. That is, they signed the consent form and agreed to participate 
but did not actually complete the first survey including the demographic information. 
Reasons for non-completion included taking the hard copies of the Time 1 survey home and 
forgetting to return it and not being able to complete the survey in clinic due to time 
constraints (e.g., having to rush to another appointment). It was later discovered that one of 
the 121 participants who started the Time 1 survey only completed part of it with responses 
yielding insufficient data to be included in the analyses. Therefore, a total of 120 participants 
had complete data at Time 1, or 67% of the patients approached about the study. An 
additional 35 participants dropped out of the study for various reasons between Times 1 and 
2 (see Figure 1 for reasons for attrition). Thus, a total of 85 participants had complete data for 
both time points (70.2% of those enrolled, or 47.4% of those initially approached).  
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Figure 1. Flow diagram of participant recruitment and retention. 
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Procedures 
Baseline (Time 1) Data Collection  
Patients’ electronic medical records were screened to determine their eligibility for 
the study by a member of the study team. Patients who qualified were approached during 
their outpatient appointments in radiation or medical oncology. The study team member 
entered the patient’s exam room, introduced themselves, explained the purpose and 
requirements of the study, and provided the opportunity for the patient to ask questions. The 
team member also asked the patient to report the date they were diagnosed with cancer in 
order to confirm that the diagnosis was within six month time frame stipulated by the 
inclusion criteria. If the patient qualified and agreed to participate, informed consent was 
obtained, and a copy of the consent form was offered to the participant. The participant was 
then asked to provide a working email address that could be used to send the link for the 
Time 2 survey. If the participant did not have an email address or declined to provide it, they 
were permitted to complete the Time 2 survey in person or via mail (see Time 2 data 
collection). Next, the participant completed the Time 1 questionnaire on site in the exam 
room. The majority of questionnaires was completed electronically on an iPad using 
REDCap, which is a secure web-based data collection platform for research studies. It 
encrypts all participant data and is capable of sending secure links via email for survey data 
collection. If the participant indicated that they preferred to complete the Time 1 survey on 
paper, this was permitted. After completing the Time 1 questionnaire, the participants were 
instructed to return the iPad or hard copy of the survey packet to the nurse’s station where a 
study team member or a designated member of the nursing staff retained it. After data 
49 
 
collection was complete for the day, the iPad and survey were stored in a locked cabinet. In 
addition to the questionnaire information gathered from the participants, medical information 
(see Measures Section below) was abstracted from the patients’ electronic medical records. 
For patients who refused to participate, the date of refusal and reason for refusal were 
documented, and they were thanked for their time.  
At the beginning of data collection participants were permitted, if requested, to either 
take the Time 1 questionnaire packets home and return them to the same clinic or to complete 
the Time 1 questionnaire via a REDCap link sent to their email. With each format they were 
required to complete the survey within one week of enrollment. However, this process 
proved to be unsuccessful because only two of the nine participants who requested these 
options returned the Time 1 surveys. As such, this process was discontinued early on in the 
data collection process, and participants were only permitted to complete the Time 1 surveys 
in clinic. Of the participants who had complete data at Time 1, 62.5% completed the Time 1 
survey in-person using a hard copy of the survey, 36.7% completed it in-person on the iPad, 
and 0.8% completed it via a REDCap email link. 
Six Week Follow-Up (Time 2) Data Collection  
Six weeks following the participants’ enrollment date, they were re-contacted to 
complete the follow-up study surveys. Depending on the participant’s preference, the Time 2 
surveys were completed online using REDCap (58.8%), in-person using a hard copy 
(40.0%), or in-person on an iPad using REDCap (1.2%). Completing hard copy surveys via 
USPS mail was also an option, but none of the participants opted for this option.  
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For those who opted to complete the surveys online using REDCap, the survey was 
sent as a link via email to the email address they provided at the time of enrollment. The 
email included a brief introductory statement reminding the participant of the purpose of the 
study. One to two days prior to sending the survey emails, the participants were called to 
encourage them to check their email and to remind them to complete the surveys. If the 
participants did not complete the survey within four days of the email being sent, they were 
contacted via phone to remind them to complete the survey. Up to three reminder phone calls 
were placed.  
If the participants initially chose to complete the Time 2 survey in person, attempts 
were made to administer the survey at a medical appointment that fell within the six-week 
follow-up data collection period. Such appointments included but were not limited to: 
outpatient medical, support services (psychology, dietitian, social work, financial 
counseling), imaging, laboratory, chemotherapy administration, etc. The study team member 
met the participant at the respective appointment and administered the survey. Hard copies of 
the surveys were then entered into REDCap and stored in a locked cabinet.  
In an effort to prevent attrition, the study team tracked whether participants who 
initially opted to complete the REDCap surveys online also had scheduled clinic 
appointments corresponding with the six-week follow-up data collection time point. If they 
did have a corresponding appointment, a member of the study team would approach them in 
clinic and offer two options for data completion: completing the survey that day in clinic or 
continue with the initial REDCap option. The majority of participants preferred to complete 
the survey in clinic. Thus, of the participants who originally expressed a preference to 
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complete the Time 2 surveys electronically, 27.5% actually completed them in-person using 
the iPad or hard copies. Across data collection modalities, participants were considered lost 
to follow-up if they did not complete the Time 2 survey within two weeks of the six-week 
follow-up data collection date, or eight weeks after the Time 1 survey was administered. The 
reason for attrition was documented for all patients who failed to complete the Time 2 
survey. 
Measures 
The demographic form described below was only administered at Time 1. The 
remaining study materials, including the SBAC and other validated measures, were 
administered at both time points. In addition to the administered self-report questionnaire, 
medical information was abstracted from the participants’ electronic medical records.   
Demographic Form 
An adapted version of the standard KUCC Support Services demographic form was 
used to assess for demographic and medical variables at Time 1 (see Appendix A-1). This 
broad form includes a number of demographic characteristics, but the current study focused 
on the following variables: email address, date of appointment, date of birth, age, cancer 
diagnosis, date of diagnosis, type(s) of treatment received, gender, race/ethnicity, relationship 
status, employment status, education level, approximate annual income, and current alcohol 
and tobacco use.  
Self-Blame Attributions for Cancer 
The SBAC (Eways et al., 2020) was used to assess CSB and BSB. This is an 11-item 
measure with two distinct subscales: five items assessing CSB and six assessing and BSB 
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(see Appendix A-2). The response options range from 0 (not at all) to 4 (completely) and are 
summed to create total scores for each subscale. Higher scores reflect higher levels of self-
blame. Prior work (Harry et al., 2018) using a version of this scale to assess self-blame 
attributions in a sample of underserved patients with CVD has provided evidence for good 
internal consistency for both the BSB and CSB subscales (α = .93 and α = .87, respectively), 
as well as good discriminant validity. Similar results were found in the more recent study 
(Eways et al., 2020) using the SBAC as a measure of self-blame in a heterogeneous sample 
of patients with cancer undergoing radiation treatment: The reliability coefficients for BSB 
and CSB were α = .95 and α = .93, respectively, and the measure also evidenced good 
convergent and discriminant validity. The baseline Cronbach’s alpha coefficients for the BSB 
(α = .95) and CSB subscales (α = .93) in the current study were excellent.  
Control Appraisals  
The six-item personal control subscale of the Illness Perception Questionnaire-
Revised scale (IPQ-R; Moss-Morris et al., 2002) was used to assess for health control 
appraisals, which was the mediator variable in this study (see Appendix A-3). This subscale 
is a frequently used measure to assess a person’s perceptions of personal control over their 
illness and can be adapted for particular groups by replacing the word “illness” with the 
name of the particular condition. For the current study, “illness” was replaced with the word 
“cancer.” Respondents are asked to indicate the extent to which they agree with each 
statement using a five-point scale (1 = strongly disagree, 5 = strongly agree). Items 4 and 6 
are reverse coded, and all of the items are then summed to obtain an overall score of personal 
control. Higher scores indicate more perceived personal control over one’s ability to control 
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symptoms of the illness (maximum score = 30). The overall IPQ-R has exhibited good 
internal consistency, test-retest reliability, and convergent, discriminant, and predictive 
validity in patients with multiple medical conditions (Moss-Morris et al., 2002). The personal 
control subscale has also been found to be an independent factor with good reliability (α = 
.81). This subscale has been frequently used in patients with cancer (Ashley et al., 2013; 
Henselmans et al., 2010; Howren et al., 2013; Scharloo et al., 2005), and has shown good 
reliability (α = .79) in these samples (Ashley et al., 2013; Henselmans et al., 2010). In the 
current study, the baseline scale also evidenced acceptable internal consistency (α = .77). 
Health Outcomes  
Four specific domains of the PROMIS-43 version 2.0 (Ader, 2007; Cella et al., 2010; 
Pilkonis et al., 2011) were used to measure the following health outcomes: psychological 
distress (symptoms of anxiety and depression), physical functioning, and social functioning. 
These domains are described in more detail in the subsections below. The PROMIS-43 is a 
frequently utilized self-report measure that assesses self-reported health in medical patient 
populations, including cancer (Jensen et al., 2017). The PROMIS-43 was developed using 
Item Response Theory to allow for the subset of any items from a larger bank to effectively 
estimate the domain score. Each item is on a five-point scale, with the qualitative response 
options varying by domain. Scores are calculated by first summing the response values to 
each question within each domain. Total raw scores are then transformed into T-scores to 
provide a norm-based score that can be compared to the general population. In the United 
States, the mean score for any of the PROMIS-43 domains is 50 with a standard deviation of 
10. A higher PROMIS-43 T-score indicates more of the concept being measured. For 
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example, a T-score of 60 on the Anxiety domain represents worse than average anxiety 
symptoms.  
Psychometric investigations of the PROMIS-43 (Cella et al., 2010; Lin et al., 2014) 
have demonstrated that it is a reliable and valid measure for assessing multiple dimensions of 
health-related quality of life, with internal consistency estimates ranging from good (α = .89) 
to excellent (α. = 95) for each domain (Lin at al., 2014). Psychometric support for the use of 
PROMIS-43 with patients with cancer is also sufficient (Jensen et al., 2017), and researchers 
(Stachler et al., 2014) have concluded that the PROMIS-43 instruments are appropriate and 
valid tools for assessing quality of life within this population. Importantly, it is also the 
preferred assessment measure for health-related quality of life for patients at KUCC and is 
widely distributed throughout the outpatient clinics as it is considered to provide clinically 
meaningful information. 
Depressive Symptoms 
Depressive symptoms were measured using the six-item Depression domain of the 
PROMIS-43. Using a five-point response scale (1 = never, 5 = always), respondents indicate 
the frequency with which they have experienced certain depressive symptoms within the last 
seven days. Higher scores represent greater levels of depressive symptoms. Assessment of 
fixed and short forms of the Depression domain have evidenced good inter-item reliability, 
and convergent, discriminant, and clinical validity (Choi et al., 2014; Jensen et al., 2017; Lin 
et al., 2014; Schalet et al., 2016) in general and health populations. The reliability coefficient 
for the baseline Depression domain in this sample was (α = .94), evidencing excellent 
reliability.  
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Anxiety Symptoms 
Anxiety symptoms were measured using the six-item Anxiety domain of the 
PROMIS-43. Response options are on a five-point scale (1 = never, 5 = always) and 
respondents are asked to indicate the frequency with which they have experienced symptoms 
of anxiety within the last seven days. High scores mean greater levels of anxiety symptoms. 
Psychometric investigations of the Anxiety domain have provided evidence for strong 
internal consistency, alternate form reliability, and construct validity (Cella et al., 2010; 
Jensen et al., 2017; Lin et al., 2014). In addition, this subscale has shown clinical utility 
across a variety of medical samples, including patients with cancer (Schalet et al., 2016). The 
internal consistency for the baseline Anxiety domain in this sample was excellent (α = .93.). 
Physical Health 
Physical health was assessed using the Physical Function domain of the PROMIS-43 
and the participant’s current level of substance use. 
Physical Function. Participants’ level of physical functioning was assessed using the 
six-item Physical Function domain of the PROMIS-43. The first four items of the domain ask 
individuals to report how difficult it is to do certain tasks that require some level of physical 
exertion. Response options for these items are on a five-point scale (1 = unable to do, 5 = 
without any difficulty). The remaining two items ask individuals how limited they are by their 
health in doing certain tasks. The response options for these questions also use a five-point 
scale with these anchors: 1 = cannot do to 5 = not at all. Higher scores represent greater 
levels of physical functioning. Research has indicated that the Physical Function domain is a 
reliable and valid measure for assessing levels of physical health functioning in patients with 
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cancer (Jensen et al., 2017), including those from diverse backgrounds (Jensen et al., 2015). 
The reliability coefficient for the baseline Physical Function domain was excellent (α = .94). 
Substance Use. Participant’s current level of substance use was assessed using the 
following questions from the demographic form: 1) “Over the last 7 days, how many 
alcoholic drinks have you consumed in total?”, 2) “Over the last 7 days, how frequently have 
you smoked cigarettes?”, and 3) “Over the last 7 days, how frequently have you used other 
types of tobacco (such as cigars, chew, snuff, e-cigarettes)?” The response option for the first 
item was the number of drinks consumed. The response options for the tobacco items were 
informed by the Center for Disease Control and Prevention’s Behavioral Risk Factor 
Surveillance System Survey Questionnaire (Centers for Disease Control and Prevention, 
2018). The responses were reverse coded for the current project such that higher scores 
indicate a higher frequency of smoking (1 = not at all, 2 = some days, 3 = every day). 
Responses to each tobacco use question were summed to create a composite tobacco use 
frequency score, with a maximum score of 6.  
Social Functioning  
Participants’ levels of ability to participate in social roles and activities was measured 
using the six-item Ability to Participate in Social Roles and Activities domain (abbreviated 
as the Social Function domain hereafter) of the PROMIS-43. Each item assesses how 
frequently respondents have trouble or are limited in their ability to engage in pleasurable 
activities. Response options are on a five-point scale (1 = always, 5 = never). High scores 
mean greater levels of social functioning. Empirical findings have provided support for the 
internal consistency and clinical validity of the Social Function domain across a number of 
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chronic health conditions, including cancer (Cella et al., 2010; Cook et al., 2016; Hahn et al., 
2016). The baseline Social Function domain in this study demonstrated excellent internal 
consistency (α = .95). 
Avoidant Coping 
Guided by prior researchers (Aarstad et al., 2008; Oancea et al., 2018; Sherman, et 
al., 2000; Voth & Sirois. 2009), avoidant coping strategies were assessed using the 
combination of three subscales from the Brief COPE inventory (Carver, 1997): denial, self-
distraction, and behavioral disengagement, which consist of two items each (see Appendix 
A-4). That is, the responses to the three individual subscales were summed to create one 
composite score of avoidant coping. The Brief COPE is an abbreviated version of the full 
COPE Inventory (Carver et al., 1989) and is a well-validated and widely used self-report 
measure for assessing various coping patterns. Each item provides a four-point response 
scale ranging from 1 to 4 (1 = I haven't been doing this at all, 4 = I've been doing this a lot). 
Values are summed for each subscale, with a maximum total score of 24 for the composite 
measure. Higher scores indicate higher use of that respective type of coping. Each subscale 
has shown moderately acceptable to good internal consistency in samples of individuals 
recovering from natural disaster (denial α = .54, self-distraction α = .71, behavioral 
disengagement α = .65). Composite scales derived from the denial, self-distraction, and 
behavioral disengagement subscales of the COPE inventory have also shown acceptable 
reliability (α = .71; Sanders et al., 2010). Similarly, the composite baseline scale in this study 
showed acceptable internal consistency (α = .71). 
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Medical Information (Abstracted from the Medical Record) 
In addition to the information on the demographic form, medical information was 
also abstracted from the medical chart and included: Cancer diagnosis, cancer stage, date of 
diagnosis, and type(s) of treatment received. 
Data Analysis  
Preliminary Statistics 
The statistical program SPSS 24.0 (2016) was used to calculate preliminary, 
descriptive, and inferential statistics. All data were screened for errors and assumptions prior 
to testing the hypotheses. First, Little’s Missing Completely at Random Test (MCAR) (Little, 
1988) was utilized to confirm that any missing data were missing in a random pattern. 
Results of this test indicated that the data were missing at random. Thus, Expectation 
Maximization imputation procedure was used to impute the missing values, which were less 
than 5.0% of the data.   
Following data imputation, the data were screened for assumptions required by 
ordinary least squares (OLS) and logistic regression analyses. Skewness and kurtosis 
statistics, histograms, and normal P-P plots of the standardized residual values were obtained 
for all dependent variables to test for multivariate normality. Homogeneity of variance was 
tested by examining scatterplots displaying the relationships between the predicted values 
and standardized residual values. Simple boxplots were used to identify outliers. Chi-square 
and independent samples t-tests were performed to make comparisons between participants 
who completed both time points and those who dropped out of the study after Time 1 on 
important demographic and medical variables. Pearson correlations, independent samples t-
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tests, and chi-square tests were conducted to identify covariates that should be included in the 
analyses. Finally, both Pearson and point-biserial correlations were used to assess the 
relationships between the study variables.  
Hypothesis Testing 
Hierarchical linear regression was used to test the hypotheses about the cross-
sectional and longitudinal relationships between both types of self-blame and the majority of 
the outcomes, with the exception of alcohol and tobacco use because these variables were 
treated as categorical and were tested using binary logistic regression. To test the cross-
sectional predictions (Hypotheses #1 and #3) using hierarchical linear regression, covariates 
were entered in the first block, the Time 1 BSB or CSB values were entered in the second 
block, and the respective Time 1 continuous outcome variable (depressive symptoms, anxiety 
symptoms, physical function, social function, or avoidant coping) was entered as the 
dependent variable. A similar approach was taken for the binary logistic regression: 
covariates were entered in the first block, Time 1 BSB or CSB was entered in the second 
block, and either Time 1 tobacco or alcohol use was entered as the outcome variable.  
The longitudinal hypotheses (Hypotheses #2 and #4) were tested by entering the 
covariates and the Time 1 outcome variables (to control for baseline levels) in the first block, 
the Time 1 BSB or CSB variable in the second block, and the Time 2 continuous outcome 
variables (depressive symptoms, anxiety symptoms, physical function, social function, or 
avoidant coping) as the dependent variables. For the binary logistic regression, the covariates 
and Time 1 outcome variables (to control for baseline levels) were entered in the first block, 
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the Time 1 BSB or CSB variable was entered in the second block, and the Time 2 tobacco or 
alcohol use variable was entered as the dependent variable. 
The PROCESS add-on for SPSS (Hayes, 2013) was used to test the proposed 
mediational hypotheses (Hypotheses #5 and #6). A total of 14 mediational analyses were 
conducted, and all were run using Model 4 of the macro. Estimates for the indirect effects 
utilized bias-corrected bootstrap confidence intervals at the 95% level based on 5,000 
samples. Time 1 BSB or CSB was entered as the predictor variable, Time 1 control 
appraisals was entered as the mediating variable, and one of the seven Time 2 outcome 
variables (depressive symptoms, anxiety symptoms, physical function, social function, 
avoidant coping, alcohol use, tobacco use) was entered as the dependent variable. Significant 
covariates were entered in the covariate section of the model.    
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CHAPTER 4 
RESULTS 
Participant Characteristics 
Table 3 displays participant characteristics. The average age of study participants was 
62.29 years (SD = 11.09), with a range from 33 to 85 years. The majority of participants was 
male (57.5%) and White (86.7%). In addition, most participants were partnered (60.0%), had 
at least some college education (67.5%), and reported an annual household income of 
$40,000 or greater (60%). Nearly 28% of participants were employed part- or full-time, with 
another 44.2% identifying as retired. The average time since diagnosis at the time of study 
enrollment was 9.10 weeks (SD = 6.27), or a little over two months (range = 0.86 to 24.71 
weeks). There were more participants with a lung cancer diagnosis (55%) compared to 
head/neck (45%), and the most common subtypes of cancer were non-small cell lung (50%) 
and pharynx cancer (27.5%). Across diagnoses, Stage IV was the most common cancer stage 
(35%). Finally, a majority of individuals (27.5%) reported undergoing a combination of 
cancer treatment modalities by the Time 1 data collection point. Note that participants’ stage 
of disease did not change from Times 1 to 2, with the exception of two cases in which the 
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stage at Time 1 was initially unknown but was later confirmed through additional medical 
work-up.  
Comparisons between Completers and Non-Completers 
There were no significant differences at baseline between those who completed both 
time points of the study (n = 85) versus those who did not complete Time 2 (n = 35) for the 
following variables: age [t(118) = 0.41, n.s.], gender [χ2(1) = 0.21, n.s.], ethnicity/race [χ2(1) 
= 0.62, n.s.], relationship status [χ2(1) = 0.10, n.s], education level [χ2(5) = 1.75, n.s.], 
household income [χ2(6) = 9.28, n.s.], cancer diagnosis [χ2(2) = 1.78, n.s.], cancer stage 
[χ2(6) = 3.60, n.s.], types of treatment received by Time 1 [χ2(6) = 3.31, n.s.], and number of 
weeks since diagnosis [t(118) = -1.12, n.s.]. There was, however, a significant difference in 
employment status between completers and non-completers [χ2(1) = 4.47, p = .034.], with 
higher rates of unemployment (including medical leave and retirement) reported by 
participants who completed the study. Thus, some caution is warranted when making 
generalizations beyond this sample to other head/neck and lung cancer populations.  
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Table 3 
 
Descriptive Statistics of Participants Characteristics  
 Total N = 120 
Participant Characteristic M (SD) 
Age (years) 62.29 (11.09) 
# weeks since diagnosis 9.10 (6.27) 
 % 
Gender  
   Male 57.5 
   Female 42.5 
Race  
   White/European American 86.7 
   Hispanic/Latino 1.7 
   Black/African American 10.0 
   Native Hawaiian/Pacific Islander 0.8 
   Asian 0.8 
Relationship Status  
   Single  16.7 
   Partnered/married 60.0 
   Separated 0.8 
   Divorced 10.8 
   Widowed 10.0 
   Not Reported 1.7 
Employment Status  
   Full-time 21.7 
   Part-time 5.8 
   Unemployed 8.3 
   Medical Leave 8.3 
   Retired 44.2 
   Disability 10.8 
   Not Reported 0.8 
Education Level  
   Less than high school  3.3 
   High school or GED 29.2 
   Some college, no degree        25.8 
   Postsecondary/Associate’s degree 5.8 
   Bachelor’s degree 15.8 
   Graduate/Professional 20.0 
 table continues 
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Note. SCLC = Small cell lung cancer; aif participants received a combination of single-
modality treatments, they were only included in this category; bExamples include but are not 
limited to angiogenesis inhibitors, epidermal growth factor receptor inhibitors, anaplastic 
lymphoma kinase inhibitors. 
 
 
Participant Characteristic % 
Approx. Household Income  
    <$10,000 9.8 
    $10,000-19,999 10.2 
    $20,000-29,999 4.2 
    $30,000-39,999 9.2 
    $40,000-49,999 10.8 
    $50,000-59,999 7.5 
    ≥$60,000 41.7 
    Not Reported 6.7 
Cancer Diagnosis  
    Lung 55.0 
      Non-small cell 50.0 
      Small cell 5.0 
    Head/Neck 45.0 
      Oral cavity 7.5 
      Pharynx 27.5 
      Larynx 2.5 
      Sinuses/Nasal Cavity 1.7 
      Salivary glands 3.3 
      Unspecified Head/Neck 2.5 
Cancer Stage  
    Stage I 13.3 
    Stage II 14.2 
    Stage III 21.7 
    Stage IV 35.0 
  Limited (SCLC only)  
 
2.5 
    Extensive (SCLC only) 2.5 
    Unknown 10.8 
Treatment received by Time 1  
    Chemotherapy alone 6.7 
    Surgery alone 16.7 
    Radiation therapy alone 5.8 
    Immunotherapy alone 2.5 
    Combination of anya 37.5 
    Otherb 3.3 
    None 27.5 
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Preliminary Analyses and Descriptive Statistics 
Descriptive statistics of the study variables (see Table 4) and examination of 
histograms revealed that avoidant coping, alcohol use, and tobacco use variables at both time 
points violated the assumption of normality. In an attempt to improve the distribution of the 
avoidant coping variable at both time points, log transformations were applied to the 
variables. The transformation improved the skew and kurtosis. Thus, the analyses were re-
run using the log transformed variables as the outcomes. Results of these analyses were 
essentially the same as the original analyses, with no change in the level of significance. 
Additionally, Times 1 and 2 avoidant coping variables met all other assumptions for OLS 
regression, and the Hayes’ (2013) macro used to test for mediation is robust to non-normality 
because it uses a bootstrapping technique. Therefore, the decision was made to retain only 
the results of the non-transformed values for the avoidant coping variable, which will be 
presented here. 
 In regards to alcohol use at Times 1 and 2, the majority of participants replied “0” 
such that the scores were inflated at this value and were not normally distributed. Therefore, 
this item was recoded into a dichotomous variable—scores equal to zero were recoded into 0 
= “no alcohol use,” and scores greater than zero (indicating an endorsement of alcohol use in 
the last seven days) were recoded into 1 = “current alcohol use.” Similarly, the majority of 
participants replied, “1 = not at all” to the tobacco use items and so scores were inflated at 
two for the composite use frequency score variable. Therefore, this item was recoded into a 
dichotomous variable, with composite scores of two recoded into 0 = “no tobacco use” and  
scores greater than two (indicating an endorsement of any tobacco use in the last seven days) 
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recoded into 1 = “current tobacco use.” Consistent with the categorical nature of the 
substance use variables, logistic regression was used for the analyses with these variables as 
the outcomes. These variables met all assumptions for logistic regression. The remaining 
study variables met all other assumptions required by OLS linear regression.  
Table 4 displays the descriptive statistics for the study variables, and Table 5 outlines 
the correlations among all study variables. Results of the analyses used to identify covariates 
via correlation analyses and independent samples t-tests for the continuous outcome variables 
(depressive symptoms, anxiety symptoms, physical function, social function, and avoidant 
coping) are depicted in Tables 6 and 7, respectively. Tables 8 and 9 display the results of chi-
square and t-test analyses, respectively, which were used to identify covariates for the 
categorial outcome variables (tobacco and alcohol use). The significant variables in these 
tables were included as covariates in the respective regression and mediation analyses.  
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Table 4 
Descriptive Statistics for the Study Variables 
Note. BSB = behavioral self-blame; CSB = characterological self-blame; T1 = Time 1; T2 = Time  
Study Variable M SD Range Skew Kurtosis 
T1 BSB  9.14 7.82 0-24 0.37 -1.13 
T2 BSB 7.67 7.20 0-24 0.67 -.74 
T1 CSB 3.21 4.73 0-20 1.82 2.88 
T2 CSB 2.67 4.03 0-20 1.74 3.30 
T1 Control appraisals  22.01 4.24 6-30 -0.43 0.65 
T2 Control appraisals  21.43 4.46 8-30 -0.64 0.81 
T1 Depressive symptoms  48.10 9.40 38.4-74.8 0.61 -0.54 
T2 Depressive symptoms 49.36 9.42 38.4-69.4 0.26 -1.15 
T1 Anxiety symptoms 53.51 9.73 39.1-74.1 -0.13 -0.93 
T2 Anxiety symptoms 52.05 9.57 39.1-70.2 -0.00 -1.13 
T1 Physical function 41.55 9.62 21.6-58.7 0.14 -0.27 
T2 Physical function 41.03 8.31 21.6-58.7 0.47 0.35 
T1 Social function  46.87 9.12 26.7-65.0 0.26 -0.18 
T2 Social function 45.47 9.50 26.7-65.0 0.33 0.07 
T1 Avoidant coping 9.59 3.18 6-19 1.02 0.52 
T2 Avoidant coping 9.35 3.34 6-19 1.12 0.66 
 N % 
T1 Alcohol use   
   No use 79 65.8 
   Current use 33 27.5 
   Not reported 8 6.7 
T2 Alcohol use   
   No use 65 76.5 
   Current use 16 18.8 
   Not reported 4 4.7 
T1 Tobacco use   
   No use 95 79.2 
   Current use 25 20.8 
T2 Tobacco use   
   No use 74 87.1 
   Current use 11 12.9 
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Table 5 
 
Correlations among All Study Variables
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. T1 BSB  -- .78* .56* .41* .11 .19 .16 .11 .16 .22* -.05 -.04 .15 .13 .21* .18 .10 -.06 -.03 -.09 
2. T2 BSB  -- .52* .60* .10 .24* .21 .27* .21 .28* -.09 .-18 .10 .09 .09 .11 -.13 .-14 .-3 .08 
3. T1 CSB  
 
-- .64* .18 .10 .19* .18 .18 .24* -.18 -.22* .18 .01 .18 .22 -.25* -.24* .25* .16 
4. T2 CSB  
  
-- .06 .05 .34* .50* .16 .42* -.14 -.22* -.06 -.07 .09 .14 -.15 -.19 .15 .37* 
5. T1 Cont  
   
-- .55* -.12 .03 -.01 -.04 .14 .07 -.02 -.08 -.06 -.06 .15 -.05 .07 -.10 
6. T2 Cont      -- -.01 .00 .01 .03 .06 .09 -.01 -.02 -.18 -.12 .02 -.02 .12 -.15 
7. T1 Dep       -- .62* .69* .58* -.14 -.29* .11 .04 .14 .14 -.41* -.36* .41* .27* 
8. T2 Dep         -- .47* .76* -.24* -.43* -.13 -.18 .10 .14 -.39* -.53* .37* .47* 
9. T1 Anx          -- .62* -.08 -.29* .18 .06 .18 .14 -.31* -.38* .49* .26* 
10. T2 Anx          -- -.26* .40* .01 -.10 .24* .21 -.30* -.47* .29* .45* 
11. T1 PF           -- .61* .07 .13 -.24* -.28* .72* .40* -.13 -.06 
12. T2 PF            -- -.10 .06 -.25* -.29* .49* .81* -.20 -.22* 
13. T1 Alca               -- .67* .09 -.01 .08 .05 .11 .00 
14. T2 Alca              -- -.11 -.09 .16 .30* .00 -.06 
15. T1 Toba               -- .81* -.33* -.25* .13 .27* 
16. T2 Toba                -- -.29* -.19 .05 .18 
17. T1 Soc                 -- .48* -.33* .21 
18. T2 Soc                  -- -.25* -.21 
19. T1 Cop                   -- .38* 
20. T2 Cop                    -- 
Note. BSB = behavioral self-blame; CSB = characterological self-blame; Cont = control appraisals; Dep = depressive symptoms; Anx = anxiety symptoms; PF = physical function;  
Alc = alcohol use; Tob = tobacco use; Soc = social function; Cop = avoidant coping. 
aCorrelations between the alcohol and tobacco use variables were conducted using point-biserial correlations. All other correlations were conducted using Pearson correlations.  
  *at least p < .05 
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Table 6 
 
Results of Correlation Analyses for Identifying Possible Covariates for the Continuous 
Outcome Variables 
 
 Possible covariates 
Outcome Age Weeks since diagnosis Education Income 
T1 Depressive symptoms -.20* .09 -.12 -.09 
T1 Anxiety symptoms  -.26* -.07 -.17 -.14 
T1 Physical function -.18* -.18 .23* .43* 
T1 Social function -.05 -.12 .16 .30* 
T1 Avoidant coping -.20* -.09 -.11 -.07 
T2 Depressive symptoms -.03 -.02 -.20 -.23* 
T2 Anxiety symptoms  -.09 .06 -.25* -.35* 
T2 Physical function -.12 -.05 .30* .42* 
T2 Social function .03 -.04 .19 .26* 
T2 Avoidant coping -.10 .01 -.19 -.22* 
Note. T1 = Time 1; T2 = Time 2 
*at least p < .05 
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Table 7 
 
Results of t-test Analyses for Identifying Possible Covariates for the Continuous Outcome 
Variables 
 
 
Possible covariate 
 Gender Race/Ethnicity Relationship   status 
Employment 
status Cancer type 
 
Outcome 
 
Female 
 
Male 
 
White 
Non-
White 
 
Yes 
 
No 
 
Yes 
 
No 
 
Lung 
 
HNC 
T1 Depressive 
symptoms 
 
47.61 
(9.84) 
48.45 
(9.05) 
48.13 
(9.06) 
47.88  
(11.61) 
48.69 
(9.67) 
47.44 
(8.98) 
46.73 
(8.76) 
48.44 
(9.54) 
47.32 
(9.25) 
49.02 
(9.57) 
T1 Anxiety 
symptoms 
 
55.19 
(9.69) 
52.30 
(9.65) 
53.08 
(9.69) 
56.34 
(9.84) 
53.59 
(10.00) 
53.63 
(9.34) 
53.72 
(9.27) 
53.21 
(9.79) 
53.36 
(10.02) 
53.70 
(9.46) 
T1 Physical 
function 
 
41.49 
(9.29) 
41.59 
(9.92) 
42.14 
(9.38) 
 
37.74 
(10.61) 
42.36 
(9.28) 
40.35 
(10.31) 
48.19 
(8.81) 
39.11 
(8.73) 
39.28 
(9.66) 
44.32 
(8.90) 
T1 Social 
function 
 
47.18 
(10.57) 
46.65 
(7.99) 
47.15 
(8.90) 
 
45.06 
(10.61) 
46.80 
(8.90) 
47.13 
(9.74) 
51.40 
(8.58) 
45.15 
(8.81) 
46.47 
(9.64) 
47.38 
(8.52) 
 
T1 Avoidant 
coping 
 
9.70 
(2.86) 
9.51 
(3.42) 
9.29 
(3.00) 
11.50 
(3.74) 
9.69 
(3.44) 
9.50 
(2.79) 
9.50 
(3.03) 
9.57 
(3.24) 
9.58 
(3.13) 
9.60 
(3.27) 
T2 Depressive 
symptoms 
 
5.79 
(9.30) 
48.32 
(9.47) 
48.91 
(9.39) 
52.65 
(9.51) 
48.84 
(10.05) 
50.58 
(8.27) 
45.90 
(8.39) 
51.21 
(9.55) 
50.19 
(9.24) 
48.33 
(9.68) 
T2 Anxiety 
symptoms 
 
53.83 
(10.35) 
51.51 
(8.96) 
 
51.84 
(9.53) 
57.09 
(8.93) 
51.83 
(9.85) 
53.37 
(9.30) 
49.28 
(9.45) 
54.03 
(9.40) 
 
53.38 
(9.04) 
51.28 
(10.21) 
T2 Physical 
function 
 
40.29 
(8.01) 
41.54 
(8.55) 
41.76 
(8.25) 
35.53 
(6.79) 
41.87 
(7.71) 
39.35 
(9.06) 
45.27 
(8.61) 
39.03 
(7.39) 
39.81 
(8.11) 
42.59 
(8.41) 
T2 Social 
function 
45.10 
(9.37) 
45.73 
(9.68) 
46.31 
(9.61) 
39.21 
(5.78) 
45.67 
(9.91) 
45.19 
(9.10) 
48.31 
(10.09) 
44.10 
(9.04) 
44.99 
(9.69) 
46.09 
(9.35) 
           
T2 Avoidant 
coping 
10.32 
(3.29) 
8.67 
(3.24) 
9.18 
(3.44) 
10.60 
(2.12) 
9.01 
(3.12) 
9.91 
(3.71) 
9.20 
(2.93) 
9.48 
(3.55) 
9.42 
(3.49) 
9.25 
(3.19) 
Note. Mean (SD); T1 = Time 1; T2 = Time 2; HNC = head/neck cancer; significantly different values at least 
p < .05 are bolded 
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Table 8 
 
Results of Chi-Squared Analyses for Identifying Possible Covariates for the Categorical Tobacco and Alcohol Use Outcome  
Variables 
Note. n (%); T1 = Time 1; T2 = Time 2; HNC = head/neck cancer; significantly different values at least p < .05 are bolded 
 
 
 
  Possible covariate 
Outcome  Gender Race/Ethnicity Relationship   status Employment status Cancer type 
 
  
 
Female 
 
Male 
 
White 
Non-
White 
 
Yes 
 
No 
 
Yes 
 
No 
 
Lung 
 
HNC 
T1 Tobacco 
use  
No use 41 
(34.2) 
54 
(45.0) 
82 
(68.3) 
13 
(10.8) 
53 
(44.2) 
40 
(33.3) 
33 
(27.5) 
61 
(50.8) 
49 
(40.8) 
46 
(38.3) 
 Current use 10  
(8.3) 
15 
(12.5) 
22 
(18.3) 
3  
(2.5) 
19 
(15.8) 
6  
(5.0) 
0  
(0.0) 
25 
(20.8) 
17 
(14.2) 
8 
 (6.7) 
            
T1 Alcohol 
use 
No use 38 
(31.7) 
41 
(34.2) 
67 
(55.8) 
12 
(10.0) 
51 
(42.5) 
27 
(22.5) 
25 
(20.8) 
54 
(45.0) 
43 
(35.8) 
36 
(30.0) 
 Current use 10  
(8.3) 
23 
(19.2) 
31 
(25.8) 
2  
(1.7) 
19 
(15.8) 
14 
(11.7) 
7  
(5.8) 
25 
(20.8) 
19 
(15.8) 
14 
(11.7) 
               
T2 Tobacco 
use 
No use 28 
(32.9) 
46 
(54.1) 
66 
(77.6) 
8 
(9.4) 
44 
(51.8) 
29 
(34.1) 
27 
(31.8) 
46 
(54.2) 
40 
(47.1) 
34 
(40.0) 
 Current use 7  
(8.2) 
4 
(4.7) 
9  
(10.6) 
2  
(2.3) 
8 
(9.4) 
3 
(3.5) 
1 
(1.2) 
10 
(11.8) 
8  
(9.4) 
3 
(3.5) 
            
T2 Alcohol 
use 
No use 28 
(32.9) 
37 
(43.5) 
57 
(67.1) 
8  
(9.4) 
38 
(44.7) 
26 
(30.6%) 
22 
(25.9) 
43 
(50.6) 
31 
(36.5) 
34 
(40.0) 
    Current use 7  
(8.2) 
9 
 (10.6) 
16 
(18.8) 
0 
(0.0) 
10 
(11.8) 
6 
(7.1%) 
5  
(5.9) 
10 
(11.8) 
13 
(15.3) 
3 
(3.5) 
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Table 9 
 
Results of t-test Analyses for Identifying Possible Covariates for the Categorical Alcohol and 
Tobacco Use Outcome Variables  
Note. Mean (SD) T1 = Time 1; T2 = Time 2; significantly different values at least p < .05 are bolded 
 
 
 
Results of Hypothesized Models 
Hypotheses for Behavioral-Self Blame 
Hypothesis #1 
Results of the hierarchical linear regressions analyzing the cross-sectional 
relationships between baseline levels of BSB and health outcomes indicated that BSB was 
non-significantly related to Time 1 depressive symptoms (controlling for age), Time 1 
anxiety symptoms (controlling for age), Time 1 physical function (controlling for age, 
  Possible Covariate 
 
  Age 
Weeks since 
diagnosis Education Income 
T1 Tobacco use  No use 63.01 
(11.61) 
8.94 
(6.36) 
3.80 
(1.64) 
5.16 
(2.10) 
 Current use 59.56 9.71 2.92 4.64 
  (10.59) (5.98) (1.26) (2.48) 
      
T1 Alcohol use No use 61.09 
(11.02) 
9.77 
(6.28) 
3.63 
(1.63) 
4.93 
(2.12) 
 Current use 64.27 7.03 3.73 5.47 
     (10.77) (5.25) (1.59) (2.26) 
      
T2 Tobacco use No use 62.69 
(10.14) 
9.16 
(6.45) 
3.68 
(1.67) 
5.20 
(2.16) 
 Current use 57.55 
(12.10) 
11.86 
(7.19) 
3.36 
(1.43) 
5.18 
(2.09) 
      
T2 Alcohol use No use 61.31 
(10.69) 
9.86 
(6.69) 
3.55 
(1.69) 
5.13 
(2.16) 
    Current use 64.13 
(10.71) 
8.03 
(5.62) 
4.00 
(1.41) 
5.84 
(1.65) 
  
73 
 
education, income, employment status, and cancer type), Time 1 social function (controlling 
for income and employment status), and Time 1 avoidant coping (controlling for age and 
race/ethnicity). See Models 1-5 in Table 10 for results of these analyses. 
In regards to the Time 1 substance use outcomes, results of the binary logistic 
regressions showed that BSB was not associated with Time 1 alcohol use (controlling for the 
number of weeks since diagnosis; see Table 11). However, baseline BSB was positively and 
significantly associated with Time 1 tobacco use (controlling for education and employment 
status). The overall model was significant [χ2 (3) = 26.79, p < .001] and correctly classified 
79.0% of the cases. As shown in Table 11, participants who had higher levels of BSB were 
more likely to report current tobacco use (in the last seven days) than those lower in BSB. 
Thus, Hypothesis #1 was not supported because the only significant relationship identified 
was between baseline levels of BSB and Time 1 tobacco use, which was not in the expected 
direction (negative).  
Hypothesis #2 
Results of the hierarchical linear regression analyses examining the relationships 
between baseline levels of BSB and Time 2 continuous outcomes are presented in Table 10 
(see Models 6-10). Findings indicated that BSB at Time 1 was non-significantly related to 
Time 2 depressive symptoms (controlling for income, employment status, and Time 1 
depressive symptoms), Time 2 anxiety symptoms (controlling for education, income, 
employment status, and Time 1 anxiety symptoms), Time 2 physical function (controlling for 
education, income, race/ethnicity, employment status, and Time 1 physical function), Time 2 
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social function (controlling for income, race/ethnicity, and Time 1 social function), and Time 
2 avoidant coping (controlling for income, gender, and Time 1 avoidant coping).  
Results from the binary logistic regression indicated that BSB was not significantly 
related to Time 2 alcohol use (controlling for cancer type and Time 1 alcohol use) or Time 2 
tobacco use (controlling for Time 1 levels). See Table 11 for the results of these analyses. 
Therefore, Hypothesis #2 was not supported because baseline levels of BSB did not 
significantly predict any of the Time 2 health outcomes. Note that both the cross-sectional 
and longitudinal regression analyses with BSB as the predictor variable were re-run without 
the non-significant covariates in an attempt to conserve degrees of freedom and increase 
power, but the results remained the same. 
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Table 10 
 
Results of the Hierarchical Linear Regression Analyses Predicting Times 1 and 2 Continuous Outcomes from BSB 
Regression Model F(df) R2 Δ R2 B B SE β 
 
Model 1: Predicting T1 depressive symptoms 
      
   Step 1 4.71(1,114)* .04 --    
     Age    -0.17 0.08 -.20* 
   Step 2  2.79(1,113) .06 .02    
     BSB    0.18 0.11 .15 
Model 2: Predicting T1 anxiety symptoms       
   Step 1  8.43(1,117)* .07 --    
     Age    -0.23 0.08 -.25* 
    Step 2 2.81(1,116) .09 .02    
     BSB    0.19 0.11 .15 
Model 3: Predicting T1 physical function       
   Step 1  9.46(5,105)* .31 --    
     Age     -0.03 0.08 -.03 
     Education    0.56 0.56 .09 
     Income    1.14 0.42 .26* 
     Employment status    -6.13 2.00 -.30* 
     Cancer type    3.72 1.63 .19* 
   Step 2 0.00(1,104) .31 .00    
       BSB    0.00 0.10 .00 
Model 4: Predicting Time 1 social function       
   Step 1 8.55(2,108)* .14 --    
     Income    0.92 0.40 .22* 
     Employment status    -4.61 1.95 -.23* 
   Step 2 0.84(1,107) .14 .01    
     BSB    -0.10 0.10 -.08 
table continues  
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Regression Model F(df) R2 Δ R2 B B SE β 
Model 5: Predicting T1 avoidant coping       
   Step 1 5.15(2,117)* .08 --    
     Age     -0.05 0.03 -.16 
     Race/ethnicity    1.95 0.84 .21* 
   Step 2  0.12(1,116) .08 .00    
     BSB    -0.01 0.04 -.03 
Model 6: Predicting T2 depressive symptoms       
   Step 1  20.26(3,72)* .46 --    
     Income       -0.08 0.43 -.02 
     Employment status    3.31 1.87 .17 
     Time 1 depressive symptoms    0.68 0.10 .64* 
    Step 2  0.24(1,71) .46 0.00    
       BSB    0.05 0.11 .04 
Model 7: Predicting T2 anxiety symptoms       
   Step 1  17.44(4,75)* .48 --    
     Education    -0.33 0.56 -.05 
     Income    -0.78 0.43 -.18 
     Employment status    3.75 1.91 .18* 
     Time 1 anxiety symptoms    0.60 0.08 .59* 
   Step 2 1.82(1,74) .49 0.01    
      BSB    0.14 0.10 .11 
Model 8: Predicting T2 physical function       
   Step 1  11.19(5,74)* .43 --    
     Education     0.62 0.51 .12 
     Income     0.36 0.42 .09 
     Race/Ethnicity    -2.80 2.21 -.12 
     Employment status    -1.59 1.84 .08 
     Time 1 physical function    0.42 0.09 .49* 
table continues 
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Regression Model F(df) R2 Δ R2 B B SE β 
   Step 2 0.04(1.73) .43 0.00    
       BSB    -0.02 0.09 .02 
Model 9: Predicting T2 social function       
   Step 1 9.89(3,76)* .28 --    
     Income    0.43 0.45 .10 
     Race/Ethnicity    -2.23 1.13 -.19 
     T1 social function     0.45 0.10 .44* 
Step 2 0.53(1,75) .28 0.00    
     BSB    -0.03 0.12 -.02 
Model 10: Predicting T2 avoidant coping       
Step 1 7.72(3,76)* .23 --    
     Income    -0.29 0.15 -.19 
     Gender    -.155 0.68 -.23* 
     Time 1 avoidant coping    0.38 0.11 .36* 
Step 2 0.35(1.75) .24 0.00    
BSB    -0.03 0.04 -.06 
Note. T1 = Time 1; T2 = Time 2; BSB = behavioral self-blame  
*at least p < .05 
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Table 11 
 
Results of the Logistic Regression Analyses Predicting Times 1 and 2 Alcohol and Tobacco use from BSB 
Note. T1 = Time 1; T2 = Time 2; BSB = behavioral self-blame; OR = odds ratio; CI = confidence interval. R2 = Nagelkerke R Square 
*at least p < .05
Regression Model R2 B SE Wald P Value OR (95% CI) 
 
Model 1: Predicting T1 alcohol use 
 
 
     
   Step 1 .06      
     Weeks since diagnosis  -0.08 -0.04 4.46 .04 0.91(0.85-0.99)* 
   Step 2  .10      
     BSB  0.04 0.03 2.59 .11 1.05(0.99-1.10) 
Model 2: Predicting T1 tobacco use       
   Step 1  .23      
     Employment status  0.48 0.17 7.72 .01 1.61(1.15-2.25)* 
     Education  -0.36 0.17 4.77 .03 0.69(0.50-0.96)* 
    Step 2 .31      
     BSB  0.09 0.03 7.52 .01 1.10(1.03-1.17)* 
Model 3: Predicting T2 alcohol use       
   Step 1  .45      
     Cancer type  -1.12 0.50 5.03 .03 0.33(0.12-0.87)* 
     Time 1 alcohol use  0.30 0.10 8.18 .00 1.34(1.10-1.64)* 
   Step 2 .45      
       BSB  -0.04 0.04 0.01 .92 1.00(0.92-1.08) 
Model 4: Predicting T2 tobacco use       
   Step 1 .77       
     Time 1 tobacco use  4.62 1.22 14.44 .00 102.27(9.40-1112.55)* 
   Step 2 .77      
     BSB  0.03 0.07 0.21 .64 1.03(0.90-1.19) 
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Hypotheses for Characterological Self-Blame 
Hypothesis #3 
Results of the analyses examining the cross-sectional relationships between CSB and 
Time 1 health outcomes indicated that Time 1 CSB was significantly and positively related to 
baseline depressive symptoms [β = .18, t(113) = 1.97, p = .05], controlling for age. CSB also 
accounted for a significant proportion of the variance in depressive symptoms, R2 = 
.07, F(1,113) = 3.89, p =.05 and increased the explained variance in the first block by an 
additional 3.0%, ΔR2 = .03 (see Table 12, Models 1-5 for results of the cross-sectional 
analyses with CSB as the predictor). The positive relationship between CSB and Time 1 
anxiety symptoms approached significance (p = .07) after controlling for age, but CSB did 
not account for a significant amount of variance in the outcome. In addition, CSB was non-
significantly related to Time 1 physical function (controlling for age, education, income, 
employment status, and cancer type). The relationship between CSB and Time 1 social 
function was in the expected direction (negative) and trended towards significance (p = .06) 
but did not significantly increase the amount of variance explained after controlling for 
income and employment status. Baseline CSB was positively and significantly related to 
Time 1 avoidant coping [β = .23, t(116) = 2.61, p = .01] and accounted for a significant 
proportion of the variance in the outcome, R2 = .13, F(1,116) = 6.83, p =.01. The addition of 
CSB in block 2 also increased the explained variance in the first block by an additional 
11.0%, ΔR2 = .11. 
Table 13 provides the results of the binary logistic regressions analyzing relationships 
between baseline levels of CSB and Time 1 alcohol and tobacco use. As expected, the model 
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predicting Time 1 alcohol use from CSB was significant [χ2 (2) = 9.39, p < .01] and correctly 
classified 71.4% of the cases. In other words, participants reporting higher levels of CSB at 
Time 1 were more likely to report using alcohol in the last seven days than their lower-CSB 
counterparts, after controlling for the number of weeks since diagnosis. On the other hand, 
the cross-sectional relationship between Time 1 CSB and tobacco use (controlling for 
employment status and education) was not significant. In summary, Hypothesis #3 was 
partially supported in that baseline CSB was, as expected, positively related to depressive 
symptoms, avoidant coping, and alcohol use. The relationships between CSB and Time 1 
anxiety symptoms and social function were also in the expected directions and approached 
significance. However, Time 1 CSB was not significantly related to the other health 
outcomes (physical function and tobacco use).  
Hypothesis #4 
Table 12 (Models 6-10) presents the results of the longitudinal analyses between 
baselines levels of CSB and the Time 2 continuous outcome variables. Findings indicated 
that CSB at Time 1 was non-significantly related to Time 2 depressive symptoms 
(controlling for income, employment status, and Time 1 depressive symptoms), Time 2 
anxiety symptoms (controlling for education, income, employment status, and Time 1 
anxiety symptoms), Time 2 physical function (controlling for education, income, 
race/ethnicity, employment status, and Time 1 physical function), Time 2 social function 
(controlling for income, race/ethnicity, and Time 1 social function), and Time 2 avoidant 
coping (controlling for income, gender, and Time 1 avoidant coping).  
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Table 13 displays the relationships between Time 1 CSB and Time 2 alcohol and 
tobacco use. The binary logistic regression analyses revealed that Time 1 CSB did not 
longitudinally predict alcohol use (controlling for cancer type and Time 1 alcohol use) or 
tobacco use (controlling for Time 1 levels). Thus, these results do not provide support for 
Hypothesis #4 because Time 1 CSB did not significantly predict any of the Time 2 health 
outcomes. Note that both the cross-sectional and longitudinal regression analyses with CSB 
as the predictor variable were re-run without the non-significant covariates to try to 
conserve degrees of freedom and increase power, but the results remained the same. 
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Table 12 
 
Results of the Hierarchical Linear Regression Analyses Predicting Times 1 and 2 Continuous Outcomes from CSB 
Regression Model F(df) R2 Δ R2 B B SE β 
Model 1: Predicting T1 depressive symptoms       
   Step 1 4.71(1,114)* .04 --    
     Age    -0.17 0.08 -.20* 
   Step 2  3.89(1,113)* .07 .03    
     CSB    0.36 0.18 .18* 
Model 2: Predicting T1 anxiety symptoms       
   Step 1  8.44(1,117)* .07 --    
     Age    -0.23 0.08 -.26* 
    Step 2 3.46(1,116) .09 .03    
     CSB    0.34 0.18 .17 
Model 3: Predicting T1 physical function       
   Step 1  9.46(5,105)* .31 --    
     Age     -0.03 0.08 -.03 
     Education    0.56 0.56 .09 
     Income    1.14 0.42 .26* 
     Employment status    -6.13 2.00 -.29* 
     Cancer type    3.72 1.63 .19* 
   Step 2 0.76(1,104) .32 .01    
       CSB    -0.15 .17 -.07 
Model 4: Predicting Time 1 social function       
   Step 1 8.54(2,108)* .14 --    
     Income    0.92 0.40 .22* 
     Employment status    -4.61 1.95 -.23* 
   Step 2 3.48(1,107) .16 .03    
     CSB    -0.33 0.18 -.17 
table continues 
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Regression Model F(df) R2 Δ R2 B B SE β 
Model 5: Predicting T1 avoidant coping       
   Step 1 5.15(2,117)* .08 --    
     Age     -0.05 0.03 -.16 
     Race/ethnicity    1.95 0.84 .21* 
   Step 2  6.83(1,116) .13 .11    
     CSB     0.15 0.06 .23* 
Model 6: Predicting T2 depressive symptoms       
   Step 1  19.91(3,74)* .45 --    
     Income       -0.47 0.40 -.11 
     Employment status    3.75 1.95 .18 
     Time 1 depressive symptoms    0.60 0.09 .60* 
    Step 2  0.02(1,73) .45 0.02    
       CSB     0.02 0.18 .01 
Model 7: Predicting T2 anxiety symptoms       
   Step 1  17.44(4,75)* .48 --    
     Education    -0.3 0.56 -.05 
     Income    -0.78 0.43 -.18 
     Employment status    3.75 1.91 .18 
     Time 1 anxiety symptoms    0.58 0.08 .59* 
   Step 2 0.58(1,74) .49 0.00    
      CSB    0.14 0.18 .07 
Model 8: Predicting T2 physical function       
   Step 1  11.19(5.74)* .43 --    
     Education     0.62 0.51 .12 
     Income     0.36 0.42 .10 
     Race/Ethnicity    -2.80 2.21 -.12 
     Employment status    -1.59 1.85 -.09 
     Time 1 physical function    0.42 0.09 .49* 
table continues 
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Regression Model F(df) R2 Δ R2 B B SE β 
   Step 2 1.15(1,73) .44 0.01    
     CSB     -0.17 0.16 -.10 
Model 9: Predicting T2 social function       
   Step 1 9.70(3,76)* .28 --    
     Income    0.37 0.46 .08 
     Race/Ethnicity    -5.19 2.81 -.19 
     T1 social function     0.46 0.11 .44* 
Step 2 1.51(1,75) .29 0.01    
     CSB    -0.22 0.20 .11 
Model 10: Predicting T2 avoidant coping       
Step 1 7.72(3,76)* .23 --    
Income    -0.29 0.15 -.19 
Gender    -1.55 0.68 -.23* 
Time 1 avoidant coping    0.38 0.11 .36* 
Step 2 0.68(1,75) .24 0.01    
CSB    0.06 0.08 .09 
Note. T1 = Time 1; T2 = Time 2; CSB = characterological self-blame  
*at least p £ .05.
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Table 13 
 
Results of the Logistic Regression Analyses Predicting Times 1 and 2 Alcohol and Tobacco use from CSB 
Note. T1 = Time 1; T2 = Time 2; CSB = characterological self-blame; OR = odds ratio; CI = confidence interval; R2 = Nagelkerke R Square 
*at least p < .05 
Regression Model R2 B SE Wald P Value OR (95% CI) 
 
Model 1: Predicting T1 alcohol use 
      
   Step 1 .06      
     Weeks since diagnosis  -0.09 0.04 4.46 .03 0.92(0.85-0.99)* 
   Step 2  .11      
     CSB  0.10 0.05 4.25 .04 1.10(1.01-1.21)* 
Model 2: Predicting T1 tobacco use       
   Step 1  .23      
     Employment status  0.48 0.17 7.72 .01 1.61(1.15-2.25)* 
     Education  -0.37 0.17 4.77 .03 0.69(0.50-0.96)* 
    Step 2       
     CSB .26 0.08 0.05 2.90 .09 1.08(0.99-1.19) 
Model 3: Predicting T2 alcohol use       
   Step 1  .45      
     Cancer type  -1.12 0.50 5.03 .03 0.33(0.12-0.87)* 
     Time 1 alcohol use  0.30 0.10 8.18 .00 1.34(1.10-1.64)* 
   Step 2 .45      
     CSB  -0.04 0.09 0.25 .62 0.96(0.81-1.14) 
Model 4: Predicting T2 tobacco use       
   Step 1 .77      
     Time 1 tobacco use  4.63 1.22 14.44 .00 102.27(9.40-112.55)* 
   Step 2 .77      
   CSB  0.01 0.12 0.01 .91 1.01(0.80-1.29) 
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Hypotheses for Control Appraisals as a Mediator 
Hypothesis #5 with BSB as the Predictor Variable 
 Depressive Symptoms. Results of the mediation analyses with Time 2 depressive 
symptoms as the outcome variable indicated that bootstrapped 95% confidence intervals for 
the indirect effect contained zero [-0.04, 0.08], meaning that the relationship between Time 1 
BSB and Time 2 depressive symptoms was not significantly mediated by Time 1 control 
appraisals (see Table 14). The direct effects of BSB and control appraisals on depressive 
symptoms were also non-significant, after controlling for income, employment status, and 
Time 1 depressive symptoms. 
 
 
 
Table 14 
 
Model Coefficients for Hypothesis #5: Mediation between BSB, Control Appraisals, and 
Depressive Symptoms 
Note. T1 = Time 1, T2 = Time 2, BSB = Behavioral self-blame 
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Depressive 
Symptoms) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 BSB) a 0.05 0.06 .42 c´ 0.04 0.11 .71 
M (T1 Control appraisals)  --- --- --- b 0.26 0.20 .20 
Income  i1 .0.02 0.25 .94 i1 -0.11 0.43 .80 
Employment status   i2 -1.86 1.11 .10 i2 3.67 1.92 .06 
T1 Depressive symptoms i3 -0.02 0.06 .66 i3 0.69 0.10 .00 
         
 R2 = .05 
F(4, 71) = 1.01, p = .41 
         R2 = .47 
      F(5, 70) =  12.53, p < .001  
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 Anxiety Symptoms. As shown in Table 15, results of the mediation analyses with 
Time 2 anxiety symptoms as the outcome variable showed that bootstrapped 95% confidence 
intervals for the indirect effect contained zero [-0.03, 0.03], indicating that the relationship 
between Time 1 BSB and anxiety symptoms was not significantly mediated by Time 1 
control appraisals. Additionally, the direct effects of BSB and control appraisals on anxiety 
symptoms were not significant, after controlling for education, income, employment status, 
and Time 1 anxiety symptoms. 
 
 
 
Table 15 
 
Model Coefficients for Hypothesis #5: Mediation between BSB, Control Appraisals, and 
Anxiety Symptoms 
Note. T1 = Time 1, T2 = Time 2, BSB = Behavioral self-blame 
 
 
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Anxiety 
Symptoms) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 BSB) a 0.04 0.06 .56 c´ 0.16 0.11 .14 
M (T1 Control Appraisals)  --- --- --- b -0.03 0.20 .87 
Education i1 0.02 0.38 .96 i1 -0.10 0.64 .88 
Income i2 0.01 0.31 .97 i2  -0.56 0.52 .29 
Employment status i3 -1.76 1.13 .12 i3 3.91 1.96 .05 
T1 Anxiety symptoms i4 -0.01 0.05 .89 i4 0.60 0.09 .00 
         
 R2 = .04 
F(5, 72) = 0.63, p = .68 
         R2 = .49 
      F(6, 71) =  11.50, p < .001  
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 Physical Function. These results indicated that bootstrapped 95% confidence 
intervals for the indirect effect contained zero [-0.04, 0.03]. This suggests that the 
relationship between Time 1 BSB and Time 2 levels of physical function was not 
significantly mediated by Time 1 control appraisals (see Table 16). In addition, the direct 
effects of BSB and control appraisals on physical function were non-significant, after 
controlling for education, income, race/ethnicity, employment status, and Time 1 physical 
function. 
 
 
 
Table 16 
 
Model Coefficients for Hypothesis #5: Mediation between BSB, Control Appraisals, and 
Physical Function 
Note. T1 = Time 1, T2 = Time 2, BSB = Behavioral self-blame 
  
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Physical 
Function) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 BSB) a 0.02 0.06 .69 c´ -0.09 0.09 .37 
M (T1 Control Appraisals)  --- --- --- b -0.11 0.18 .55 
Education i2 0.11 0.36 .77 i2 0.33 0.55 .56 
Income i3 -0.09 0.31 .77 i3 0.46 0.47 .33 
Race/ethnicity i4 0.14 1.54 .93 i4 -3.98 2.34 .09 
Employment status i5 -1.47 1.20 .23 i5 -1.22 1.85 .51 
T1 Physical function i6 0.04 0.06 .57 i6 0.46 0.10 .00 
         
 R2 = .04 
F(6, 72) = 0.52, p = .79 
         R2 = .43 
      F(7, 71) =  7.77, p < .001  
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Social Function. Table 17 displays the results of the analyses with social function 
included as the outcome variable. Findings showed that the bootstrapped 95% confidence 
intervals for the indirect effect contained zero [-0.05, 0.04], which suggests that the 
relationship between Time 1 BSB and Time 2 levels of social function was not significantly 
mediated by Time 1 control appraisals. The direct effects of BSB and control appraisals on 
physical function were non-significant, after controlling for income, race/ethnicity, and Time 
1 social function. 
 
 
 
Table 17 
 
Model Coefficients for Hypothesis #5: Mediation between BSB, Control Appraisals, and 
Social Function 
Note. T1 = Time 1, T2 = Time 2, BSB = Behavioral self-blame 
 
 
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Social 
Function) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 BSB) a 0.02 0.06 .71 c´ -0.09 0.12 .44 
M (T1 Control Appraisals)  --- --- --- b -0.19 0.22 .40 
Income i3 0.12 0.25 .63 i3 0.27 0.49 .58 
Race/ethnicity i4 0.28 1.54 .86 i4 -.6.60 2.98 .03 
T1 Social function i6 0.04 0.06 .44 i6 0.47 0.11 .00 
         
 R2 = .02 
F(4, 74) = 0.31, p = .87 
         R2 = .29 
      F(5, 73) =  6.09, p < .001  
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Avoidant Coping. Regarding avoidant coping, results indicated that bootstrapped 
95% confidence intervals for the indirect effect contained zero [-0.01, 0.01], suggesting that 
the relationship between Time 1 BSB and Time 2 avoidant coping strategies was not 
significantly mediated by Time 1 control appraisals (See Table 18). The direct effects of BSB 
and control appraisals on avoidant coping strategies were also non-significant, after 
controlling for income, gender, and Time 1 avoidant coping. 
 
 
 
Table 18 
 
Model Coefficients for Hypothesis #5: Mediation between BSB, Control Appraisals, and 
Avoidant Coping 
Note. T1 = Time 1, T2 = Time 2, BSB = Behavioral self-blame 
 
 
 
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Avoidant 
Coping) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 BSB) a 0.02 0.06 .73 c´ -0.01 0.04 .77 
M (T1 Control Appraisals)  --- --- --- b -0.06 0.08 .45 
Income i1 0.15 0.23 .53 i1 -0.29 0.16 .07 
Gender i2 -0.65 0.97 .51 i2 -1.34 0.68 .05 
T1 Avoidant coping i3 0.19 0.16 .22 i3 0.30 0.11 .01 
         
 R2 = .03 
F(4, 75) = 0.60, p = .66 
         R2 = .18 
      F(5, 74) = 3.30, p < .05  
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Alcohol Use. For the alcohol use outcome, results indicated that bootstrapped 95% 
confidence intervals for the indirect effect contained zero [-0.12, 0.18]. This suggests that the 
relationship between Time 1 BSB and Time 2 alcohol use was not significantly mediated by 
Time 1 control appraisals (See Table 19). The direct effects of BSB and control appraisals on 
alcohol use were non-significant after controlling for cancer type and baseline levels of 
alcohol use. 
 
 
 
Table 19 
 
Model Coefficients for Hypothesis #5: Mediation between BSB, Control Appraisals, and 
Alcohol Use 
Note. T1 = Time 1, T2 = Time 2, BSB = Behavioral self-blame, R2 = Nagelkerke R Square  
 
  
 
 
 
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  Y (T2 Alcohol Use) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 BSB) a 0.03 0.06 .67 c´ -0.00 0.06 .99 
M (T1 Control Appraisals)  --- --- --- b -0.14 0.12 .22 
Cancer type     i1 -0.04 1.01 .97 i1 -2.81 1.09 .01 
T1 alcohol use     i2 -0.65  1.12 .56 i2 4.76 1.15 .00 
         
 R2 = .01 
F(3, 74) = 0.16, p = .92 
         R2 = .67 
     -2LL(4) = 36.05, p < .001  
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Tobacco Use. Results of the mediation analysis with Time 2 tobacco use as the 
outcome can be seen in Table 20. These findings indicated that bootstrapped 95% confidence 
intervals for the indirect effect contained zero [-0.29, 1.00], indicating that the relationship 
between Time 1 BSB and Time 2 tobacco use was not significantly mediated by Time 1 
control appraisals. The direct effects of BSB and control appraisals on tobacco use were non-
significant after controlling for Time 1 levels of tobacco use. 
 
 
 
Table 20 
 
Model Coefficients for Hypothesis #5: Mediation between BSB, Control Appraisals, and 
Tobacco Use 
Note. T1 = Time 1, T2 = Time 2, BSB = Behavioral self-blame, R2 = Nagelkerke R Square  
 
 
 
Taken together, the results of these mediation analyses do not provide support for 
Hypothesis #5. That is, Time 1 control appraisals did not significantly mediate the 
relationships between Time 1 BSB and any of the Time 2 health outcomes.  
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Tobacco  
Use) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 BSB) a 0.04 0.06 .55 c´ 0.08 0.08 .32 
M (T1 Control Appraisals)  --- --- --- b 0.20 0.16 .20 
T1 Tobacco Use     i1 -1.40 1.29 .28 i1 6.33 1.66 .00 
         
 R2 = .02 
F(2, 82) = 0.71, p = .50 
                  R2 = .75 
     -2LL(3) = 21.82, p < .001  
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Hypothesis #6 with CSB as the Predictor Variable 
 Depressive Symptoms. Results of the analysis examining the relationship between 
CSB, control appraisals, and Time 2 depressive symptoms showed that bootstrapped 95% 
confidence intervals for the indirect effect contained zero [-0.07, 0.20], indicating that the 
relationship between Time 1 CSB and Time 2 depressive symptoms was not significantly 
mediated by Time 1 control appraisals (See Table 21). After controlling for income, 
employment status, and Time 1 depressive symptoms, CSB was positively and directly 
related to Time 1 control appraisals [a = 0.22, t(71) = 2.00, p = .05], but neither CSB nor 
control appraisals elicited a direct effect on Time 2 depressive symptoms.  
 
 
 
Table 21 
 
Model Coefficients for Hypothesis #6: Mediation between CSB, Control Appraisals, and 
Depressive Symptoms 
Note. T1 = Time 1, T2 = Time 2, CSB = Characterological self-blame 
  
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Depressive 
Symptoms) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 CSB) a 0.22 0.11 .05 c´ -0.05 0.20 .80 
M (T1 Control Appraisals)  --- --- --- b 0.28 0.21 .18 
Income      i1 0.08 0.25 .74 i1 -0.11 0.43 .80 
Employment status       i2 -2.28 1.11 .04 i2 3.92 1.98 .05 
T1 Depressive symptoms i3 -0.04 0.06 .49 i3 0.69 0.10 .00 
         
 R2 = .10 
F(4, 71) = 1.87, p < .12 
         R2 = .47 
      F(5, 70) =  12.50, p < .001  
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Anxiety Symptoms. Mediation results with Time 2 anxiety symptoms as the outcome 
variable are displayed in Table 22. These results showed that bootstrapped 95% confidence 
intervals for the indirect effect contained zero [-0.12, 0.07]. This showed that the relationship 
between Time 1 CSB and Time 2 anxiety symptoms was not significantly mediated by Time 
1 control appraisals. Further, the direct effects of CSB and control appraisals on anxiety 
symptoms were non-significant, after controlling for education, income, employment status, 
and Time 1 anxiety symptoms. 
 
 
 
Table 22 
 
Model Coefficients for Hypothesis #6: Mediation between CSB, Control Appraisals, and 
Anxiety Symptoms 
Note. T1 = Time 1, T2 = Time 2, CSB = Characterological self-blame
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Anxiety 
Symptoms) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 CSB) a 0.21 0.12 .08 c´ 0.16 0.21 .45 
M (T1 Control Appraisals)  --- --- --- b 0.05 0.21 .83 
Education i1 -0.13 0.38 .74 i1 -0.12 0.67 .86 
Income i2 0.14 0.31 .66 i2  -0.46 0.54 .41 
Employment status i3 -2.14 1.23 .06 i3 3.87 2.04 .06 
T1 Anxiety symptoms i4 -0.02 0.05 .74 i4 0.61 0.09 .00 
         
 R2 = .08 
F(5, 72) = 1.22, p = .31 
         R2 = .48 
      F(6, 71) =  10.99, p < .001  
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Physical Function. Analyses with physical function as the dependent variable 
showed that bootstrapped 95% confidence intervals for the indirect effect contained zero   
[-0.12, 0.06], indicating that the relationship between Time 1 CSB and Time 2 levels of 
physical function was not significantly mediated by Time 1 control appraisals (See Table 23). 
The direct effects of CSB and control appraisals on physical function were non-significant, 
after controlling for education, income, race/ethnicity, employment status, and baseline 
physical function.  
 
 
 
Table 23 
 
Model Coefficients for Hypothesis #6: Mediation between CSB, Control Appraisals, and 
Physical Function 
Note. T1 = Time 1, T2 = Time 2, CSB = Characterological self-blame 
 
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Physical 
Function) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 CSB) a 0.18 0.11 .12 c´ -0.20 0.18 .25 
M (T1 Control Appraisals)  --- --- --- b -0.08 0.18 .68 
Education i2 0.01 0.36 .99 i2 0.42 0.56 .45 
Income i3 -0.00 0.31 .99 i3 0.36 0.48 .45 
Race/ethnicity i4 0.04 1.51 .98 i4 -3.74 2.33 .11 
Employment status i5 -1.74 1.20 .15 i5 -0.97 1.87 .61 
T1 Physical function i6 0.04 0.06 .50 i6 0.45 0.10 .00 
         
 R2 = .07 
F(6, 72) = 0.92, p = .49 
         R2 = .44 
      F(7, 71) =  7.90, p < .001  
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Social Function. As shown in Table 24, results with social function included as the 
outcome variable indicated that bootstrapped 95% confidence intervals for the indirect effect 
contained zero [-0.15, 0.07], indicating that the relationship between Time 1 CSB and Time 2 
levels of social function was not significantly mediated by Time 1 control appraisals. The 
direct effects of CSB and control appraisals on physical function were non-significant, after 
controlling for income, race/ethnicity, and Time 1 social function. 
 
 
 
Table 24 
 
Model Coefficients for Hypothesis #5: Mediation between CSB, Control Appraisals, and 
Social Function 
Note. T1 = Time 1, T2 = Time 2, CSB = Characterological self-blame 
 
 
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Social 
Function) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 CSB) a 0.16 0.11 .15 c´ -0.28 0.22 .22 
M (T1 Control Appraisals)  --- --- --- b -0.15 0.23 .51 
Income i3 0.18 0.25 .47 i3 0.17 0.49 .73 
Race/ethnicity i4 0.19 1.52 .90 i4 -6.34 2.95 .03 
T1 Social function i6 0.06 0.06 .28 i6 0.45 0.11 .00 
         
 R2 = .04 
F(4, 74) = 0.82, p = .52 
         R2 = .30 
      F(5, 73) =  6.36, p < .001  
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Avoidant Coping. Regarding avoidant coping at Time 2, results indicated that 
bootstrapped 95% confidence intervals for the indirect effect contained zero [-0.05, 0.02], 
suggesting that the relationship between Time 1 CSB and Time 2 avoidant coping strategies 
was not significantly mediated by Time 1 control appraisals (See Table 25). The direct 
effects of CSB and control appraisals on avoidant coping were non-significant, after 
controlling for income, gender, and Time 1 avoidant coping.  
 
 
 
Table 25 
 
Model Coefficients for Hypothesis #6: Mediation between CSB, Control Appraisals, and 
Avoidant Coping 
Note. T1 = Time 1, T2 = Time 2, CSB = Characterological self-blame 
 
 
 
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  
Y (T2 Avoidant 
Coping) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 CSB) a 0.12 0.11 .28 c´ 0.10 0.08 .22 
M (T1 Control Appraisals)  --- --- --- b -0.07 0.08 .36 
Income i1 0.19 0.23 .41 i1 -0.25 0.16 .12 
Gender i2 -0.86 0.98 .39 i2 -1.50 0.69 .03 
T1 Avoidant coping i3 0.16 0.16 .33 i3 0.29 0.11 .01 
         
 R2 = .04 
F(4, 75) = 0.87, p = .48 
         R2 = .20 
      F(5, 79) =  3.65, p < .01  
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Alcohol Use. For the alcohol use outcome at Time 2, findings showed that 
bootstrapped 95% confidence intervals for the indirect effect contained zero [-0.33, 1.03], 
indicating that the relationship between Time 1 CSB and Time 2 alcohol use was not 
significantly mediated by Time 1 control appraisals (See Table 26). Furthermore, the direct 
effects of CSB and control appraisals on alcohol use were non-significant after controlling 
for cancer type and Time 1 levels of alcohol use. 
 
 
 
Table 26 
 
Model Coefficients for Hypothesis #6: Mediation between CSB, Control Appraisals, and 
Alcohol Use 
Note. T1 = Time 1, T2 = Time 2, CSB = Characterological self-blame; R2 = Nagelkerke R 
Square 
 
 
 
 
 
 
 
 
 
 
  Consequent 
 
 M (T1 Control 
Appraisals)  Y (T2 Alcohol Use) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 CSB) a 0.11 0.12 .34 c´ -0.03 0.09 .75 
M (T1 Control Appraisals)  --- --- --- b -0.14 0.12 .24 
Cancer type i1 -0.11 1.00 .91 i1 -2.82 1.09 .01 
T1 Alcohol use i2 -0.70 1.11 .54 i2 4.80 1.16 .00 
         
 R2 = .02 
F(3, 74) = 0.40, p = .75 
         R2 = .67 
     -2LL(4) = 35.95, p < .001  
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 Tobacco Use. Regarding tobacco use, results showed that bootstrapped 95% 
confidence intervals for the indirect effect contained zero [-0.04, 1.05], meaning that the 
relationship between Time 1 CSB and Time 2 tobacco use was not significantly mediated by 
Time 1 control appraisals (See Table 27). In addition, the direct effects of CSB and control 
appraisals on tobacco use frequency were non-significant after controlling for baseline levels 
of tobacco use.  
 
 
 
Table 27 
 
Model Coefficients for Hypothesis #6: Mediation between CSB, Control Appraisals, and 
Tobacco Use 
Note. T1 = Time 1, T2 = Time 2, BSB = Characterological self-blame; R2 =  Nagelkerke R 
Square 
 
 
 
 
Overall, the results of these mediation results do not support Hypothesis #6 because 
the relationships between Time 1 CSB and Time 2 health outcomes were not significantly 
mediated by Time 1 control appraisals.  
 
  Consequent 
 
 M (T1 Control 
Appraisals)  Y (T2 Tobacco Use) 
Antecedent  Coeff SE p  Coeff SE p 
X (T1 CSB) a 0.14 0.10 .18 c´ 0.05 0.11 .65 
M (T1 Control Appraisals)  --- --- --- b 0.17 0.14 .24 
T1 Tobacco Use     i1 -1.56 1.28 .23 i1 6.03 1.48 .00 
         
 R2 = .03 
F(2, 82) = 1.42, p = .25 
         R2 = .74 
     -2LL(3) =  22.71, p < .001  
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CHAPTER 5 
DISCUSSION 
 The present study aimed to fill important gaps in the literature by assessing the 
predictive validity of the SBAC on health outcomes in patients who received relatively recent 
diagnoses of two types of cancer with strong behavioral risk factors: HNC and lung cancer. 
The specific outcomes assessed were depressive symptoms, anxiety symptoms, physical 
function, social function, avoidant coping, alcohol use, and tobacco use. In addition to 
improving the measurement of self-blame attributions, assessing the predictive validity of the 
SBAC was expected to provide clarification around the unique effects of CSB and BSB, 
particularly in patients with these behaviorally-mediated cancer types. An additional goal of 
this project was to investigate whether the relationship between BSB and CSB and the 
abovementioned outcomes were mediated by control appraisals, as Janoff-Bulman’s (1979) 
theory contends.   
Hypotheses for Behavioral Self-Blame 
Overall, Hypothesis #1 investigating the cross-sectional relationships between 
baseline levels of BSB and health outcomes was not supported. BSB was positively and 
significantly related to Time 1 tobacco use such that higher levels of BSB were associated 
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with a higher likelihood of currently using tobacco. However, BSB was non-significantly 
related to all of the other outcome measures after controlling for pertinent covariates. These 
findings suggest that making behavioral-based attributions for a diagnosis of HNC or lung 
cancer is not beneficial and is actually associated with the deleterious health behavior of 
tobacco use.  
The positive relationship between BSB and Time 1 tobacco use is inconsistent with 
Janoff-Bulman’s (1979) theory, which posits that BSB serves as a protective factor and 
thereby should be associated with positive outcomes. It is also inconsistent with a study by 
Costanzo et al. (2005), which found that blaming one’s prior behaviors for a cancer diagnosis 
served as a motivating factor for changing future health-related behaviors, such as reducing 
smoking, in survivors of gynecological cancer. One possible explanation for the unexpected 
finding in this study is that the participants may not have identified tobacco use as a 
controllable behavior. The benefits of BSB as proposed by Janoff-Bulman (1979) are linked 
to the assumption that behavior is controllable through its modifiability. However, many 
tobacco users may not perceive their use as controllable given the highly addictive properties 
of tobacco, particularly cigarettes. An additional consideration is that tobacco use is often 
described as a salient, albeit harmful, coping strategy (Wills & Shiffman, 1985). In the 
context of the significant stressor of a recent cancer diagnosis, it would not be surprising for 
individuals to continue using tobacco or even increase their use in an attempt to manage the 
negative affect associated with the diagnosis. Resultingly, continued or increased use may 
lead to ongoing self-blame.  
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Another potential explanation for the positive relationship between BSB and tobacco 
use is that these analyses were cross-sectional. While the BSB subscale does not assess for 
specific behaviors, there is evidence that patients with lung cancer in particular readily 
identify smoking as the cause of their illness (Lehto, 2007). Therefore, it may merely be the 
case that participants who attributed their cancer diagnosis to the behavior of using tobacco 
also simultaneously used tobacco. Relatedly, these variables were assessed relatively shortly 
after participants were diagnosed. Such close proximity to the time of diagnosis may not 
have provided participants with adequate time to mobilize health behavior change, such as 
smoking cessation. Even if participants identified tobacco use as a modifiable behavior that 
caused their diagnosis, the time period immediately following diagnosis is often filled with 
urgent medical appointments and procedures such that participants may not have had the 
opportunity to access resources to help them quit.  
The non-significant relationships between BSB and all remaining Time 1 health 
outcomes are also incongruent with prior research documenting cross-sectional relationships 
between BSB and outcomes, particularly psychological distress (Bennett et al., 2013; 
Costanzo et al., 2005; Friedman et al., 2007; Glinder & Compas, 1999; Janoff-Bulman, 1979; 
Lebel, Castonguay, et al., 2013; Lebel, Feldstain, et al., 2013; Scharloo et al., 2005). 
However, these results have been highly variable in terms of the direction of their effects 
with no clear pattern: in patients with cancer, some studies have confirmed a protective effect 
of BSB (Lebel, Castonguay, et al., 2013; Timko & Janoff-Bulman, 1985), while others have 
linked it to poor outcomes (Glinder & Compas, 1999; Lebel, Feldstain et al., 2013; Scharloo 
et al., 2005). Additionally, in a study by Malcarne and colleagues (1995), BSB elicited no 
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effect on outcomes in patients with breast cancer. Therefore, while the present results do not 
support Hypothesis #1, they do reflect the historically nebulous effects of behavioral 
attributions. It was anticipated that better measurement of BSB using the SBAC would 
clarify its impact and provide support for Janoff-Bulman’s (1979) theory, but the cumulative 
results of this study and others have demonstrated that BSB may be an unreliable predictor of 
functioning following the diagnosis of a medical condition.  
Compared to the SBAC validation study (Eways et al., 2020) with a sample of 
patients with a wide variety of cancer types (M = 6.74), the present sample of patients with 
HNC and lung cancer reported relatively higher levels of BSB (M = 9.14). Since the initial 
validation study included far few participants with behaviorally-mediated cancers (HNC, 
lung cancer, and melanoma), the higher levels of behavioral attributions in the current project 
seem fitting. On the other hand, Harry (2018) assessed BSB in patients with CVD using a 
nearly identical measure to the SBAC and relative to those patients (M = 13.97), the present 
sample endorsed lower mean levels of BSB at baseline. Similarly, the calculation of a single-
item comparison score revealed that the levels of BSB in patients with CVD (M range = 
2.25-2.58; Bennett et al., 2013; Harry et al., 2015) was higher than in this sample (M = 1.52), 
as well as other samples of participants with cancer (M range = 1.12-1.90; Bennett, et al., 
2005; Eways, et al., 2020; Glinder & Compas, 1999; Malcarne, et al., 1995). The only 
exception to this was one sample of patients with HNC and lung cancer who were asked 
specifically about blaming their prior smoking and drinking behaviors (Lebel, Castonguay, et 
al., 2013). For these participants, their average BSB score (M = 2.75) was closer to the score 
of patients with CVD.  
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The levels of behavioral-based attributions in this study appear to be situated above 
other oncology populations but still lower than cardiac groups. Given the behavioral risk 
factors of HNC and lung cancer, it was expected that BSB levels in this study would be more 
similar to CVD populations, like Lebel, Castonguay, and colleagues (2013) found. These 
findings suggest that attributional processes vary by disease group. Individuals with cancer—
even behaviorally-mediated types—appear to be less likely to search for behavioral causes 
for their diagnoses unless prompted to do so with specific examples of cancer-causing 
behaviors. Considering the variations in societal and media depictions of the causes of cancer 
and CVD (Atkin et al., 2008), these differences are not surprising. That is, information about 
CVD tends to focus on behavioral origins of the disease, whereas messages about the causes 
of cancer often emphasize genetic factors and screening procedures.  
For some, a reluctance to identify one’s own behaviors as the cause of cancer may 
also be protective. For example, one qualitative study (Salander et al., 2007) found that 
among patients with lung cancer who were current smokers, the most common causal 
attribution was, “I don’t know.” The construct of disavowal was offered as a likely 
explanation for this attribution. In other words, not taking personal responsibility for the 
diagnosis was hypothesized to allow patients to—consciously or subconsciously—avoid the 
negative consequences (e.g., guilt, blame from others) associated with accepting culpability. 
Perhaps a similar cognitive process was experienced by patients in the current study, 
particularly those diagnosed with lung cancer.  
Hypothesis #2 was also not supported, as baseline levels of BSB were not related to 
any of the Time 2 health outcomes, adjusting for covariates and baseline levels of the 
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outcomes. In other words, blaming one’s behavior for a cancer diagnosis was found to be 
unrelated to mental and physical health six weeks later. These results depart from Janoff-
Bulman’s (1979) model. However, prior longitudinal analyses have identified both positive 
and negative relationships between BSB and distal outcomes in patients with cancer, 
including those with HNC and lung cancer (Bennett et al., 2005; Friedman at al., 2007; 
Glinder & Compas, 1999; Rabin & Pinto, 2006; Scharloo et al., 2010). As a result, the non-
significant findings in this study may again be due to the variable nature of BSB as a 
predictor.  
Hypothesis #2 analyses may have also been impacted by the relatively stable levels of 
the dependent variables across Times 1 and 2. After controlling for Time 1 levels of the 
health outcomes (in addition to the other covariates), there was very little variance left to be 
explained by BSB, which likely contributed to the null results. The relatively short amount of 
time (six weeks) between data collection periods may have accounted for the stability in the 
health outcomes and may have also provided an insufficient time frame to detect the long-
term effects of BSB. 
Hypotheses for Characterological Self-Blame 
 Hypothesis #3 was partially supported in that baseline levels of CSB were cross-
sectionally and positively related to Time 1 depressive symptoms, avoidant coping, and 
alcohol use after controlling for covariates. Consistent with Janoff-Bulman’s (1979) model, 
these results suggest that creating dispositional attributions for a serious medical diagnosis, 
such as HNC or lung cancer, is associated with poor outcomes. These findings also mirror 
prior research that has identified cross-sectional relationships between CSB and 
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psychological distress (Plaufcan et al., 2012), greater levels of avoidant coping (Voth & 
Sirois, 2009), and poorer adjustment (Timko & Janoff-Bulman, 1985) in medical patient 
populations.  
Research assessing the relationships between self-blame and health behaviors (e.g., 
alcohol use) has focused exclusively on BSB, thereby making comparisons to studies with 
CSB as the predictor impossible. Nonetheless, the results of this study seem to suggest that 
both types of self-blame are related to worse health behaviors in the context of HNC and lung 
cancer. This may in part be due to the well-established cycle between blame, shame, and 
substance use (Luoma et al., 2012). When individuals use substances, they often feel a great 
deal of blame and shame, which can lead to ongoing use in an attempt to manage negative 
affect associated with blame/shame. This cycle may be exacerbated following the diagnosis 
of HNC and lung cancer when stress is high and patients may struggle to discontinue 
substance use despite multiple warnings from medical providers and peers.  
Although CSB was unrelated to the other Time 1 outcomes, the relationships between 
CSB, anxiety symptoms, and social function were in the expected directions and approached 
significance (p = .06 and .07, respectively). Thus, it is possible that these relationships may 
have become significant with a larger sample size. To a lesser extent, the same may have 
been true for the relationship between Time 1 CSB and tobacco use given its relatively low 
p-value (p = .09) and the other significant relationships in this study found between self-
blame and substance use. Regarding physical function, it was found that a number of 
demographic and medical variables were related to this outcome and were subsequently 
included as covariates in the linear regression model. In turn, these covariates appear to have 
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accounted for a significant amount of the variance in physical function such that CSB did not 
add any predictive power to the model. This suggests that demographic and medical 
variables, particularly income, employment status, and cancer type, may have a more 
substantial impact on one’s physical status than their level of CSB. Taken together, these 
cross-sectional findings are consistent with the pattern of results found in the literature: when 
compared to BSB, CSB has more dependably been linked to poor outcomes.  
 CSB levels in the current study (M = 3.21) were shown to be slightly higher than 
those documented in the SBAC validation study (M = 2.74; Eways et al., 2020) but were less 
than half the amount identified by a prior study (Harry, 2018) using the equivalent CSB 
subscale for patients with CVD (M = 6.97). After calculating a single-item average score to 
allow for comparisons between the current CSB subscale and other single-item measures, 
results confirmed that the levels in this project (M = 0.64) were lower than those in previous 
samples of patients with CVD, with values ranging from 1.72 to 1.74 (Bennett et al., 2013; 
Harry, et al., 2015). Additionally, the current levels of CSB were lower than in other cancer 
samples, which ranged from 1.30 to 1.56 (Bennett et al., 2005; Glinder & Compas, 1999; 
Malcarne et al., 1995). The only exception to this was the initial SBAC validation study 
(Eways et al., 2020), which found single-item levels of CSB (M = 0.55) comparable to those 
in the present study.  
Similar to what was found with behavioral attributions, patients with HNC and lung 
cancer appear to blame their character for their diagnoses to far less of an extent than patients 
with CVD. In general, they also appear to be less likely to attribute their diagnoses to their 
character when compared to patients with other types of cancer. The participants in this study 
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reported higher levels of BSB than CSB, suggesting that there is likely some recognition of 
the behavioral risk factors of HNC and lung cancer, but these levels do not rise to those 
identified by people with cardiac concerns.  
Results failed to provide support for Hypothesis #4 because Time 1 CSB was not 
significantly related to any of the Time 2 outcomes (controlling for covariates and Time 1 
levels of the outcomes). This implies that making characterological attributions for a 
diagnosis of HNC or lung cancer within six months of the diagnosis does not longitudinally 
predict health outcomes. These findings diverge from Janoff-Bulman’s (1979) theory 
asserting that there is an aversive effect of CSB on outcomes, as well as previous literature 
providing evidence for this assertion (e.g., Bennett et al., 2005; Harry et al., 2015). For 
example, studies have shown that characterological attributions predict negative health 
outcomes in patients with CVD (Harry et al., 2015; Harry, 2018), and comparable results 
have been observed in patients with cancer with links between baseline levels of CSB and 
psychological distress at multiple follow-up time points (Bennett et al., 2005; Glinder & 
Compas, 1999; Malcarne et al., 1995). While the present study did not find the same 
relationships, it did parallel Bennett and colleagues’ (2013) inquiry, which found no 
associations between CSB at the start of CR and psychological distress 12 weeks later at the 
completion of CR. As discussed previously, the stable levels in the study outcomes and the 
six week time period between Times 1 and 2 may have limited the detection of statistically 
significant effects. This implies that longer follow-ups are required to adequately test the 
predictive validity of the SBAC.  
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Mediation Hypotheses with Behavioral Self-Blame as the Predictor 
 Results of the mediation analyses with Time 1 BSB as the independent variable 
showed that the relationship between BSB and Time 2 health outcomes was not significantly 
mediated by Time 1 control appraisals, adjusting for the covariates and Time 1 levels of the 
outcomes. In addition, BSB was not significantly related to Time 1 control appraisals in any 
of the models, and control appraisals was not related to the Time 2 outcome measures. Thus, 
Hypothesis #5 was not supported.  
Janoff-Bulman (1979) argued that because behaviors are modifiable, behaviorally-
based attributions should be related to higher levels of perceived control, which should in 
turn predict better outcomes. The present study did not identify control appraisals as the 
mechanism through which BSB operates to improve outcomes in patients with HNC and 
lung cancer. However, its findings did echo those from prior studies. Malcarne and 
colleagues (1995), for instance, found that perceived control did not significantly mediate the 
relationship between BSB and psychological distress in patients with a variety of cancer 
types. Results of another study (Bennett et al., 2005) showed that neither control over breast 
cancer recovery nor control over recurrence mediated the relationship between either type of 
self-blame and anxiety and depressive symptoms. Similar results have been observed in CVD 
populations (Harry, 2018), with control appraisals failing to mediate the relationship between 
BSB and various health outcomes including psychological distress, quality of life, health 
behavior adherence, and functional capacity.  
Overall, prior research suggests that the role of control appraisals as a mediating 
variable is tenable, a conclusion which was further supported by the current study. In 
  
110 
 
addition to the nebulous nature of control as a mediator, its non-significant effect is also not 
surprising because BSB was not related to any Time 2 outcomes. Without any relationship to 
mediate, it is understandable that control appraisals was not identified as a significant 
mediator.  
The non-significant direct effects of behavioral attributions on control appraisals also 
failed to provide support for Janoff-Bulman’s (1979) theory and were dissimilar to the results 
of Bennett and colleagues’ (2013) study that documented a positive association between BSB 
and perceived control over cardiac event recurrence in a sample of patients with CVD. 
However, another study of patients with CVD (Harry, 2018) found a negative direct effect of 
BSB on control appraisals, after controlling for the number of CR sessions. These 
contradictory findings suggest that the relationship between behaviorally-focused attributions 
and control appraisals may not be as straightforward as Janoff-Bulman (1979) contended. 
Although we hoped that improved measurement of BSB using the SBAC would help to 
clarify the nature of this relationship, it continues to be difficult to characterize. Thus, more 
research with the SBAC is warranted.  
What is more surprising than the abovementioned null findings is the lack of 
significant direct effects between Time 1 control appraisals and Time 2 outcomes. The 
positive relationship between perceived control and better mental and physical health has 
long been established in medical patient populations (Eways et al., 2019; Gonzalez et al., 
2015), including those with cancer (Ranchor et al., 2010; Shabason et al., 2014). As a result, 
it was expected that personal control would be related to the current outcomes. One possible 
explanation for this is the age of participants. There is some empirical evidence (Infurna et 
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al., 2011) suggesting that control is more likely to be related to health in older age (ages 65 
and older) but not mid-life. These researchers argued that the reason for this is because 
perceived control tends to elicit more distal outcomes in younger individuals and thus are 
more difficult to detect in cross-sectional or longitudinal studies with short follow-up time 
points. Given that the present sample would be considered to be in the mid-life range (M age 
= 62.29), similar conclusions may be drawn here.  
Another reason for these null results may be the number of demographic and medical 
covariates included in the mediation models. Again, these variables likely accounted for a 
significant amount of variance in the outcomes such that the effects of perceived control were 
attenuated. In addition, prior research (Infurna et al., 2011; Ross & Mirowsky, 2002) has 
suggested that demographic variables, such as age, education and income, may be factors 
underscoring the mechanisms of the relationship between control and health outcomes. Of 
course, the lack of direct effects of control in this study may also merely be spurious or due 
to statistical limitations (e.g., low power, sampling error), which are discussed further in the 
Limitations Section below.  
Compared to other studies of patients with HNC (M range = 18.33-18.77; Scharloo et 
al., 2005; Scharloo et al., 2010) and other types of cancer (M = 19.85; Ashley et al., 2013) 
that used the IPQ-R personal control subscale to asses control appraisals, the baseline levels 
of control reported by participants in this study (M = 22.01) were slightly higher. Conversely, 
in other chronic medical conditions, such as CVD (Hermele et al., 2007) and type 2 diabetes 
(Searle et al., 2007), the present levels of control were slightly lower (M = 23.50 and M = 
23.40, respectively). Therefore, it seems that individuals with HNC and lung cancer 
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experience quantities of perceived control that rest between other cancer populations and 
individuals with medical conditions more typically associated with health behaviors.  
Given the different treatment emphases for these medical conditions, the variations in 
control appraisals intuitively make sense. Compared to other types of cancer (e.g., breast and 
prostate), there is likely more of a focus on health behavior change during HNC and lung 
cancer treatment, particularly if the patient is currently engaging in frequent tobacco or 
alcohol use (Maasland et al., 2014). Receiving messages that behavior change is important 
may permit a patient some perceived control over the treatment process and outcomes even 
when the treatment protocol and schedule (e.g., number of chemotherapy infusions) are less 
controllable (Adelstein et al., 2017). This is contrasted with the treatment for CVD and 
diabetes, which when compared to cancer has a relatively greater emphasis on behavior 
change throughout the trajectory of the disease. For example, attending CR sessions, taking 
cardioprotective medications as prescribed, and engaging in weight loss efforts are some of 
the most common recommendations for the treatment of CVD (Leon & Maddox, 2015). 
Similarly, patients with diabetes are often encouraged to monitor blood sugars and accurately 
dose insulin (if insulin dependent), monitor carbohydrate intake, and eat regular, well-
balanced meals (Leon & Maddox).  
Mediation Hypotheses with Characterological Self-Blame as the Predictor 
 The mediation analyses with Time 1 CSB as the predictor variable did not provide 
support for Hypothesis #6. In other words, Time 1 control appraisals did not significantly 
mediate the relationships between CSB and any of the Time 2 health outcomes, adjusting for 
pertinent covariates and Time 1 levels of the outcomes. Further, Time 1 control appraisals 
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was not related to any of the outcome variables, and CSB only elicited a direct effect on 
Time 1 control appraisals after controlling for income and employment status (see Table 21).  
 As discussed in the section above, these results are in contrast to the theoretical model 
proposed by Janoff-Bulman (1979) but are consistent with other research that has also failed 
to identify control appraisals as a significant mediator between self-blame attributions and 
health outcomes (Bennett et al., 2005; Harry, 2018; Malcarne et al., 1995). More specifically, 
both Bennett and colleagues (2005) and Malcarne and colleagues (1995) concluded that CSB 
did not elicit its effects on psychological distress through the mechanism of perceived 
control. These conclusions were supported by Harry et al. (2018) who documented similar 
results in patients with CVD. At this point, the research seems sufficiently inconsistent so as 
to conclude that it is unlikely that control appraisals act as a reliable mediator for the 
relationship between self-blame and outcomes.  
 The positive cross-sectional relationship between Time 1 CSB and Time 1 control 
appraisals was in the opposite direction of the hypothesis informed by theory (Janoff-
Bulman, 1979) and contradicted Bennett and colleagues (2013) who found a negative 
relationship between CSB and participants’ perceived levels of control over their general 
cardiac health and recovery from a recent cardiac event. The present finding is unexpected 
and is most likely a spurious relationship such that replications studies are warranted. Less 
likely is the possibility that creating any type of self-blame attribution—even 
characterological—in the context of HNC or lung cancer instills some level of perceived 
control. Indeed, the mere process of creating causal explanations in the context of a stressful 
event has been shown to be beneficial for psychological adjustment (Bennett, 2018; Taylor, 
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1983). Finally, similar to the mediation models with BSB as the predictor variable, no 
significant direct effects were found between Time 1 control appraisals and Time 2 health 
outcomes with CSB as the predictor. These lack of results are likely attributable to similar 
explanations outlined above (i.e., age of participants, number and types of covariates 
included in the analyses, and statistical limitations).  
Theoretical and Clinical Implications  
The SBAC was previously developed and validated to improve the measurement of 
self-blame attributions in cancer (Eways, 2020). One of the main goals of this study was to 
examine the predictive validity of the SBAC. Although the impacts of BSB and CSB have 
varied in the literature, it was anticipated that using a well-validated, multi-item measure of 
both types of self-blame would allow for more accurate and nuanced assessment of these 
constructs, which in turn would yield results consistent with Janoff-Bulman’s (1979) theory. 
A secondary aim was to examine the role of control appraisals as a mediator between each 
type of self-blame and the outcomes. The creation of self-blame attributions was considered 
to be a particularly relevant cognitive process for patients with HNC and lung cancer because 
behavioral risk factors are largely culpable for the development of these diagnoses. This is 
the first study of its kind that has attempted to examine the longitudinal impacts of BSB and 
CSB as evaluated by a multi-item subscale for each domain, which fills an important gap in 
the research literature.  
Generating behavioral attributions for the diagnosis of HNC or lung cancer was 
shown to be cross-sectionally related to tobacco use only, but this relationship was not in the 
hypothesized direction (positive). Blaming one’s character for the diagnosis, on the other 
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hand, was consistent with hypotheses in that it was found to be negatively related to Time 1 
depressive symptoms, avoidant coping, and alcohol use. In effect, these results lend support 
for the CSB pathway in Janoff-Bulman’s (1979) model, but not the pathway for BSB. They 
also suggest that both behavioral and characterological attributions are associated with well-
established behavioral risk factors for HNC and lung cancer. However, CSB seems to be 
more aversive overall because of its additional relationships with depressive symptoms and 
avoidant coping.  
The significant relationships between both types of self-blame and poor outcomes 
translate into meaningful clinical implications. To begin with, it appears appropriate for 
clinicians to assess self-blame in patients with HNC and lung cancer, making appropriate 
referrals to mental health providers or other supportive resources (e.g., support groups) in an 
attempt to prevent or decrease engagement in harmful health behaviors. Addressing CSB 
may also help to mitigate symptoms of depression and the use of maladaptive coping 
strategies. Given the relative brevity of the SBAC, it could easily be incorporated into the 
flow of outpatient oncology clinics. In addition, cognitive interventions, such as cognitive-
behavioral therapy, are recommended to help patients examine their attributional styles and 
alleviate any distress associated with them. Indeed, there is evidence to suggest that 
cognitive-based interventions are beneficial for patients with HNC and lung cancer (Duffy et 
al., 2006; Walker et al., 2013). Since the significant relationships between self-blame and 
substance use were cross-sectional, Motivational Interviewing or other health behavior 
change interventions may also prove useful for patients endorsing current tobacco and/or 
alcohol use.  
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The present results also bring into question the utility of looking backward to 
generate any type of causal attribution. Creating attributions has been shown to help 
individuals make sense of significant life stressors (Taylor, 1983), but this study found that 
attributing a diagnosis of HNC or lung cancer to prior behaviors or one’s character can lead 
to poor outcomes. This may imply that looking to the past to identify the sources of a cancer 
diagnosis is not in the best interest of the patient. As such, clinicians working with 
individuals with HNC and lung cancer should consider encouraging their patients to orient 
their focus to the present moment or the future, particularly around the time of diagnosis. In a 
time where patients’ schedules are filled with medical appointments and planning next steps, 
their attention is typically required to be on the here and now or coming weeks.  
The predictive validity of the SBAC at Time 2 follow-up was not supported by these 
results because neither BSB nor CSB longitudinally predicted health outcomes. Although this 
finding was inconsistent with the hypotheses guided by Janoff-Bulman (1979), it 
nevertheless fills an important gap in the literature because it clarifies that the inconsistent 
effects of self-blame on long-term outcomes may not be solely due to poor measurement of 
this construct. Since this is the first study of its kind, replication studies should be conducted 
prior to making any final conclusions. While these results do not point to any prospective 
effects of BSB or CSB, it still seems warranted to pay attention to the attributional styles of 
patients with HNC and lung cancer in order to prevent in-the-moment adverse effects and to 
detect any longer-term outcomes not assessed by this study (i.e., beyond six weeks).  
Control appraisals were not shown to mediate the relationships between self-blame at 
baseline and outcomes at Time 2 follow-up. Despite Janoff-Bulman’s (1979) predictions, 
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several studies at this point (Bennett et al., Harry, 2018; Malcarne et al., 1999), including this 
one, have failed to identify control appraisals as a significant mediator for the relationship 
between self-blame attributions and health outcomes. The current project supports prior 
findings that BSB and CSB do not differentially elicit their impacts through perceived 
control, but low power may have posed a barrier to finding significant results. As such, the 
present study should be replicated with larger sample sizes. If control appraisals are again 
found not to be a significant mediator, it is recommended that future research diverge from 
testing control in this way and explore its effects in some other capacity. For example, prior 
research (Christensen et al., 1999) has identified perceived control as a moderator, 
concluding that the beneficial impact of BSB is contingent upon high levels of control.    
Limitations and Future Directions 
 Despite the clinical and theoretical implications outlined above, there are limitations 
to this study that should be considered. First, the majority of participants were White (86.7%) 
and educated with at least some college (67.5%), which limits the generalizability of the 
present findings to individuals from diverse racial/ethnic and socioeconomic backgrounds. 
Second, enrollment was restricted to patients who were recently diagnosed with HNC and 
lung cancer only and who received their care at KUCC for the duration of the study. Thus, 
these inclusion criteria prevent generalizability to individuals with other types of 
behaviorally mediated cancers (e.g., melanoma), people who have been living with cancer for 
longer than six months, and those who chose to receive their care at another medical facility. 
The criteria may have also inadvertently excluded individuals living in rural parts of Kansas 
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and Missouri, as they may have been unable to travel long distances to the urban medical 
center.  
Another issue to consider is the lower than expected enrollment rate, with barriers 
primarily due to unexpected changes in providers’ clinical schedules and the presence of 
other KUCC research staff in the outpatient oncology clinics. Changes in the providers’ 
schedules made it difficult to coordinate the assignment of study team members to specific 
clinics, such that there was occasionally insufficient coverage for the number of clinics 
available for enrollment. In addition, members from other research teams were at times 
enrolling patients from the same clinics where our recruitment efforts took place. This 
intermittently made it difficult for our study team to access eligible patients. It is also 
hypothesized that some patients who were approached felt overwhelmed by being asked to 
participate in multiple studies, which likely impacted their willingness to participate in ours.  
A related limitation is the attrition rate observed in this project. Approximately 30% 
of the participants enrolled in the study did not complete the Time 2 survey. This limited the 
sample size at Time 2. Those participants who completed both time points also differed from 
those who only completed Time 1 on employment status. That is, participants who identified 
as not currently working (including medical leave and retirement) were more likely to 
complete the study than those who reported being currently employed. This suggests that 
working part- or full-time served as a barrier to study completion and may have potentially 
biased the results. Fortunately, study completers and non-completers did not significantly 
differ on any of the other demographic or medical variables.  
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Although the sample size was sufficient for cross-sectional analyses at Time 1 (N = 
120), the number of participants did not meet the required minimum to ensure detection of a 
longitudinal relationship between Times 1 and 2. Only 85 participants completed the Time 2 
questionnaire packets, and a minimum of 103 participants at both time points was needed to 
achieve 80% power and an effect size of .15 (Faul et al., 2009). Therefore, the longitudinal 
and mediation analyses may have yielded significant results with a larger sample size. In 
addition, significant direct effects between Time 1 control appraisals and Time 2 outcomes 
may have been identified as a result of a greater number of participants and statistical power.  
Another potential weakness is the relatively short time period between Times 1 and 2, 
which did not allow for the observation of longer-term effects (i.e., beyond six weeks) of 
BSB and CSB. It may have also prevented our ability to detect significant predictive effects 
of self-blame attributions on outcomes at Time 2 follow-up. Further, with the exception of 
the abstracted medical record data, all of the data collection tools relied upon self-report 
measures, which introduces the possibility for response (e.g., social desirability) and mono-
method bias. This may have potentially inflated the statistical estimates.  
Given the novelty of the SBAC and the current analyses, future empirical endeavors 
should aim to confirm these findings through replication studies. The present outcomes 
should be assessed further, and it is also recommended that other mental and physical health 
outcomes be explored. Additionally, analyses should be conducted longitudinally across 
multiple time points and well beyond six weeks to better characterize the long-term impacts 
of BSB and CSB. These investigations would ideally include large samples of participants 
from diverse ethnic/racial, geographical, and sociodemographic backgrounds in order to 
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more accurately represent the population of individuals diagnosed with HNC and lung 
cancer. It would also be interesting to extend this work to include individuals with other 
cancers linked to behavioral risk factors, such as melanoma and non-melanoma skin cancers. 
This study’s inclusion criteria aimed to capture attributional processes when they were most 
salient following a diagnosis of HNC and lung cancer (i.e., within six months of diagnosis). 
This was an important consideration, but it would also be worthwhile for future research to 
investigate whether levels of BSB and CSB vary over time and have differential impacts on 
outcomes as a result.  
To address the enrollment barriers identified in this study, it is recommended that 
large study teams be developed when conducting this type of research. It would also be ideal 
for study team members to have flexible schedules and/or large portions of their time devoted 
to enrollment and follow-up data collection efforts. To the extent possible, maximizing 
communication and coordination of clinic and research schedules with medical providers and 
other research staff would be beneficial. This can be challenging in large hospital systems, 
but nonetheless should be prioritized. Regarding attrition, future researchers may want to 
consider providing compensation at follow-up time points. Although this consideration has to 
be balanced with the risk of coercion, small monetary reimbursements may help retain 
participants across time.  
Conclusion 
This study provided limited support for Janoff-Bulman’s (1979) theory in that both 
BSB and CSB as measured by the SBAC were found to be cross-sectionally and positively 
related to poor health behaviors in a sample of patients with HNC and lung cancer. In 
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addition, CSB was found to be concurrently related to depressive symptoms and avoidant 
coping strategies. Clinical implications of these results include discouraging both types of 
self-blame and offering additional support to patients engaging in tobacco and frequent 
alcohol use. Encouraging patients to adopt present-moment or future-focused orientations 
throughout the cancer trajectory is also recommended.  
The remaining cross-sectional analyses failed to link BSB and CSB to any of the 
other Time 1 outcomes and did not provide support for the longitudinal hypotheses. As a 
result, the predictive validity of the SBAC was not established by this project. The mediation 
hypotheses were also not supported by this investigation. Nonetheless, the null findings call 
into importance the need for replication studies that address the limitations of this study and 
include larger, more diverse samples. They also offer opportunities for further inquiries into 
the role of perceived control and the investigation of various health outcomes in a variety of 
oncology populations.  
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APPENDIX A MEASURES 
A-1 Demographic Form  
 
Onco-Psychology Patient Information Sheet 
ID Number: ________  
Email address: _________________________ 
Date of enrollment: _____________________ 
Date of birth: __________________ Age: ________   
Cancer diagnosis: __________________________________________________________________ 
Date of diagnosis:  _________________________________________________________________ 
Type(s) of treatment received to date: ___________________________________________________ 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Gender: 
 Female 
 Male 
 Transgender 
 Genderqueer 
  Other (specify):________ 
        Race/Ethnicity (check all that apply): 
   White/Caucasian   Asian 
   Hispanic/Latino   Bi/Multiracial                
   Black/African American  Middle Eastern/Southwest Asian 
   American Indian/Alaska Native  Other (specify):____________ 
   Native Hawaiian/Pacific Islander 
Relationship Status: 
 Single 
 Partnered/Married 
 Separated 
 Divorced 
 Widowed 
Employment status: 
 Full-time 
 Part-time 
 Student 
 Unemployed 
 Medical Leave  
 Retired 
 Disability 
   Education level: 
   Less than high school degree 
   High school or equivalent (GED) 
   Some college, no degree 
   Postsecondary/Associate’s degree 
   Bachelor’s degree 
  Graduate/Professional degree 
Approximate Household Annual Income  
 Less than $10,000       $30,000-$39,999 
 $10,000-$19,999     $40,000-$49,999 
 $20,000-$29,999         $50,000-$59,999 
    Greater than $60,000 
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Over the last 7 days, how many alcoholic drinks have you consumed in total? ___________# drinks 
 
Over the last 7 days, how frequently have you smoked cigarettes?  
 Every day     Some days     Not at all  
 
Over the last 7 days, how frequently have you used other types of tobacco (such as cigars, chew, snuff, 
e-cigarettes)? 
 Every day     Some days     Not at all  
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A-2 Self-Blame Attributions for Cancer Scale 
SBAC 
 
Some individuals blame themselves for their cancer, whereas others do not. Please read these questions and 
circle the answer that best reflects how you feel. 
 
   
Not at 
all 
 
A little 
 
Somewhat 
 
A lot 
 
Completely 
1.  How much do you blame yourself for past behaviors 
that may have caused your cancer? 
 
0 
 
1 
 
2 
 
3 
 
4 
2. To what extent do you accept fault for behaviors 
that may have caused your cancer? 
 
0 
 
1 
 
2 
 
3 
 
4 
3.  How much do you think your past behaviors 
contributed to your cancer? 
 
0 
 
1 
 
2 
 
3 
 
4 
4. 
  
To what extent do you believe that a change in your 
behavior could have prevented your cancer? 
 
0 
 
1 
 
2 
 
3 
 
4 
5. To what extent do you feel accountable when 
thinking about past behaviors that may have caused 
your cancer? 
 
0 
 
1 
 
2 
 
3 
 
4 
6. When discussing possible causes of your cancer 
with important people in your life, to what extent 
have you blamed your past behavior?  
 
0 
 
1 
 
2 
 
3 
 
4 
7. How much do you blame the type of person you are 
for your cancer? 
 
0 
 
1 
 
2 
 
3 
 
4 
8. To what extent do you believe that a change in the 
type of person you are could have prevented your 
cancer? 
 
0 
 
1 
 
2 
 
3 
 
4 
9. How much do you blame your personality for your 
cancer? 
 
0 
 
1 
 
2 
 
3 
 
4 
10. How much do you blame yourself for being the type 
of person who has bad things, like cancer, happen to 
them? 
 
0 
 
1 
 
2 
 
3 
 
4 
11.  When discussing possible causes of your cancer 
with important people in your life, to what extent 
have you blamed your personality? 
 
0 
 
1 
 
2 
 
3 
 
4 
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A-3 Illness Perception Questionnaire-Revised (Personal Control Subscale) 
 IPQ-R 
 
We are interested in your own personal views of how you now see your current cancer diagnosis. 
Please indicate how much you agree or disagree with the following statements about your illness by ticking the 
appropriate box. 
 
 
VIEWS ABOUT YOUR ILLNESS Strongly Disagree Disagree 
Neither 
Agree 
nor 
Disagree 
Agree Strongly Agree 
1.  There is a lot which I can do to control my 
symptoms. 
 
1 
 
2 
 
3 
 
4 
 
5 
2. What I do can determine whether my cancer 
gets better or worse. 
 
1 
 
2 
 
3 
 
4 
 
5 
3.  The course of my cancer depends on me.  
1 
 
2 
 
3 
 
4 
 
5 
4. 
  
Nothing I do will affect my cancer.  
1 
 
2 
 
3 
 
4 
 
5 
5. I have the power to influence my cancer.  
1 
 
2 
 
3 
 
4 
 
5 
6. My actions will have no effect on the outcome 
of my cancer. 
 
1 
 
2 
 
3 
 
4 
 
5 
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A-4 Brief COPE Inventory (Denial, Self-Distraction, and Behavioral Disengagement 
Subscales) 
BRIEF COPE INVENTORY 
 
These items deal with ways you've been coping with the stress in your life since you found out you have cancer. 
There are many ways to try to deal with problems. These items ask what you've been doing to cope with this 
one. Obviously, different people deal with things in different ways, but we’re interested in how you've tried to 
deal with it. Each item says something about a particular way of coping. I want to know to what extent you've 
been doing what the item says. How much or how frequently. Don't answer on the basis of whether it seems to 
be working or not—just whether or not you're doing it. Use these response choices. Try to rate each item 
separately in your mind from the others. Make your answers as true FOR YOU as you can.  
 
 
I haven't 
been doing 
this at all 
I've been 
doing this a 
little bit 
I've been 
doing this a 
medium 
amount 
I've been 
doing this a 
lot 
1.  I've been saying to myself "this isn't real."  
1 
 
2 
 
3 
 
4 
2. I've been refusing to believe that it has 
happened. 
 
1 
 
2 
 
3 
 
4 
3.  I've been turning to work or other activities to 
take my mind off things. 
 
1 
 
2 
 
3 
 
4 
4. 
  
I've been doing something to think about it 
less, such as going to movies, watching TV, 
reading, daydreaming, sleeping, or shopping. 
 
1 
 
2 
 
3 
 
4 
5. I've been giving up trying to deal with it.  
1 
 
2 
 
3 
 
4 
6. I've been giving up the attempt to cope.  
1 
 
2 
 
3 
 
4 
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